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ABSTRACT 
Crystal Ann Waters: Factors increasing the flexibility of nonhomologous end joining 
(Under the direction of Dale Ramsden) 
 
Broken chromosomes can be catastrophic for an organism if misrepaired or left 
unrepaired. Mammals rely predominately on non-homologous end joining (NHEJ) to efficiently 
repair chromosome breaks, which arise as programmed intermediates to cellular processes such 
V(D)J recombination or arise due to cellular damage. These sources can generate a variety of end 
structures often lacking sequence complementarity or containing nucleotide damage. I 
determined that NHEJ makes use of low fidelity direct ligation to bypass subtle mispairs and 
radiomimetic damage. This allows cells to avoid the consequences of an unrepaired double 
strand break, while allowing other repair pathways to subsequently fix the retained damage. In 
cases where direct ligation is impeded, NHEJ employs end-processing factors (e.g. polymerases 
and nucleases) to modify ends until they are ligatable. I found that end processing proceeds non-
randomly and is driven largely by the initial end structure. I found that the gaps created by 
aligning the ends were filled by DNA Pol λ and Pol µ, making them critical for the repair of 
incompatible ends. The two polymerases were found to have distinct activities and to be 
preferentially active on distinct substrates. Interestingly, I found that these polymerases also have 
a key role nuclease-dependent resolution by NHEJ. This work has shown that NHEJ 
systematically adapts to different end structures, which demonstrates just how sophisticated and 
flexible this pathway is. 
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CHAPTER 1: INTRODUCTION 
 
1.1 DNA double strand break repair 
 
The mammalian genome experiences an onslaught of environmental and intracellular 
insults everyday, resulting in various forms of DNA damage. Although double strand breaks 
(DSBs) arise during programmed recombination events such as those in meiosis, they can also 
occur in response to damaging agents like ionizing radiation (IR) and reactive oxygen species 
(ROS). DSBs that are either left unrepaired or are misrepaired result in genomic instability. 
Consequences of this instability include mutations, translocations, and apoptosis. Thus, cells had 
to evolve methods for repairing these potentially fatal lesions. 
 Mammalian cells utilize two major pathways, homologous recombination (HR) and 
nonhomologous end joining (NHEJ), to repair DSBs (reviewed in 1). HR resolves DSBs via 
extensive end resection followed by synthesis using an intact sister chromatid as a template and 
is, consequently, considered to be the most accurate of DSB repair mechanisms. Despite its 
accuracy, HR is restricted to the S- and G2-phases of the cell cycle due to the aforementioned 
requirements (reviewed in e.g. 2, 3). NHEJ resolves DSBs by directly ligating the DNA ends. As a 
result, it is not subject to the same homology and/or synthesis requirements as HR. This 
increased flexibility allows NHEJ to occur throughout the cell cycle, which makes it a 
particularly important pathway in G1 when HR is absent (reviewed in e.g.3, 4). This increased 
flexibility comes with the downside of an increased potential for mutation during repair. Despite 
this mutagenic risk, NHEJ is the primary repair mechanism for DSBs in non-cycling mammalian 
cells. 
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1.2 Nonhomologous end joining 
 
 NHEJ begins with the recognition of the DSB by the Ku heterodimer consisting of Ku70 
and Ku80 (Figure 1.1). Ku quickly localizes to the DNA ends and loads onto the DSB ends 
through a central channel 5, 6. Once Ku is bound, DNA-PKCS is recruited; together they form the 
DNA-PK complex. Two DNA-PK complexes, one on either side of the break, interact to form a 
synaptic complex that aligns ends 7, 8. DNA-PKCS in this complex serves to control access of 
processing factors (e.g. nucleases and polymerases) to the DNA ends 9, 10, 11, 12. In the final phase, 
the DNA ligase IV/XRCC4/XLF complex is recruited in order to ligate the ends 13, 14, 15, 16, 17, 18. 
Each of these core factors is required for efficient repair of DSBs generated by exogenous and 
endogenous damage or the programmed DSBs generated during V(D)J recombination. Thus, 
deficiencies in these core factors are associated with phenotypes such as severe 
immunodeficiency and radiosensitivity 19, 20, 21, 22, 23, 24, 25. 
1.3 Low fidelity ligation 
 
 The critical step in NHEJ is ligation of the DNA ends. Ligation proceeds through a 
simple, 3-step reaction in which (1) a catalytic lysine (K273) in LIG4 is adenylated (2) the 
adenyl group is transferred to the DSB’s terminal 5’phosphate and (3) the opposing strand’s 
terminal 3’OH attacks the adenyl group (reviewed in  26). Both exogenous and endogenous 
sources of damage can generate DSBs with a wide array of end structures. Some of these end 
structures could block this simple ligation reaction. Ends may be occluded by protein such as 
aborted topoisomerase II adducts, possess damaged nucleotides such as abasic sites, or contain 
secondary structures such as hairpins or gaps 27, 28, 29. NHEJ employs a host of end processing 
enzymes that can specifically modify ends in order to render them ligatable. These enzymes and 
their activities are listed in Table 1.1 (reviewed in 30, 31). The precision of these enzymes varies 
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from precisely excising specific lesions (e.g. Ku removing abasic sites) and gap-filling 
polymerase activity to more dramatic end remodeling that can result in sequence loss (e.g. 
Artemis activity).  
Given the wide variety of possible end structures that could be present at a DSB, it is 
plausible that NHEJ might employ low-fidelity ligation to directly join imperfectly aligned ends 
– a strategy similar to that used during translesion DNA synthesis in which damage is bypassed 
rather than repaired. This would allow NHEJ to retain certain classes of damage in order to avoid 
the consequences of an unrepaired DSB. Other specialized repair pathways could then repair the 
remaining damage. Such a strategy would have the benefit of preventing sequence loss due to the 
activity of end remodelers, especially if ligation were attempted first. Thus, the ability to perform 
low-fidelity ligation would confer increased flexibility to NHEJ. In Chapter 2, I assess the ability 
of NHEJ to directly join mispaired and damaged termini via low fidelity ligation. 
Previous studies have indicated that the presence of XLF stimulated the joining of 
mispaired ends 32, 33. XLF is structurally similar to XRCC4, possessing a coil-coil stalk as well as 
a globular head domain through which it forms dimers and tetramers 17, 34. Together, XLF and 
XRCC4 dimers interact through their head domains and can form a filament that wraps around 
the DNA 34, 35, 36, 37, 38, 39, 40 (Figure 1.1). This filament may serve to further stabilize the NHEJ 
core complex and also to promote the alignment of ends. The filament may additionally allow for 
the ends to adopt different conformations that could promote ligation, which would be especially 
beneficial in the case of mispaired ends. 
Although low fidelity ligation would provide NHEJ with additional flexibility when 
repairing DSBs with incompatible ends, it is possible that some level of end processing may still 
occur. Some ends may contain damage sufficient to block even low fidelity ligation and thus 
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require end processing. In Chapter 2, I will also discuss how NHEJ could balance low fidelity 
ligation with other end processing fates in response to mispaired and damaged termini. 
1.4 Alternative End Joining 
 
There may be cases in which neither low fidelity ligation nor limited end processing 
followed by ligation may be sufficient to resolve DSBs. In these cases, DSBs may be repaired by 
an error-prone alternative end joining (Alt-EJ) pathway (reviewed in 41, 42) (Figure 1.2). DSBs 
repaired using Alt-EJ are associated with deletions and microhomology usage 43, 44. It has also 
been shown that Alt-EJ promotes chromosomal translocations (reviewed in 45, 46, 47). Alt-EJ is 
defined as end joining that is Ku and LIG4-independent 43, 44, 46, 48. The genetic requirements for 
Alt-EJ have not been fully elucidated, but there are factors that promote Alt-EJ include CtIP, 
Mre11, DNA ligase III, and PARP-1 45, 47, 49, 50, 51, 52.  
Much like HR, Alt-EJ is initiated by 5’-3’ resection of the DSB to generate long 3’ss 
DNA tails. End resection is mediated by CtIP and Mre11 49, 53, 54 and reveals microhomologies 49, 
54, 55. DNA polymerase θ then promotes annealing at these microhomologies (requiring 
microhomologies of at least 2 bp) and extends synthesis from them using the opposing strand as 
a template 56. Finally, the ends are joined by DNA ligase III 46. 
1.5 X Family Polymerases 
 
 A key step in other DNA repair pathways is the replacement of lost or damaged 
nucleotides by a polymerase. Even though NHEJ lacks an intact template strand to use to instruct 
such replacement, three members of the mammalian X family of DNA polymerases have 
nonetheless been implicated in NHEJ: polymerase l (Pol λ), polymerase m (Pol µ) and terminal 
deoxynucleotidyl transferase (TdT).  
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 These Pol X family members are small structurally similar polymerases whose primary 
roles are in repair. They have similar domain organization consisting of 3 main functional 
domains: an N-terminal BRCA 1 Carboxy-Terminal (BRCT) domain, a C-terminal catalytic 
domain and the 8 kDa domain 57 (Figure 1.3). Like other polymerases, catalysis for these 
polymerases is mediated by two divalent metals 58 (reviewed in 59, 60). Three aspartate residues in 
the catalytic domain position the metal ions. These metal ions, in conjunction with the aspartate 
residues, coordinate the alignment of the primer terminus and the incoming nucleotide for the 
nucleophyilic attack by the 3’ oxygen of the primer terminus on the α-phosphate of the incoming 
nucleotide. The BRCT domain is required for the association of the polymerases with the NHEJ 
core complex (i.e. Ku, XRCC4, LIG4) 57, 61, 62, 63, 64, 65, 66. Deletion of the BRCT domain 
eliminates this association and therefore severely reduces the ability of these polymerases to 
perform their gap-filling function during NHEJ 62, 63, 64, 66. 
  DSBs can often have damage or incompatible ends associated with them. If the damage 
is removed or there is minimal homology present in the DNA termini, the ends may align and 
generate gaps. Pol λ and Pol µ are specially equipped to resolve DSBs with gaps due to the 
presence of the 8 kDa domain and helix-hairpin-helix motifs (reviewed in 59, 60). To synthesize 
across gaps the polymerase binds the primer terminus and the 8 kDa domain contacts the duplex 
on the opposite side of the break. Hydrogen bonds between the 5’phosphate and a positively 
charged pocket in the 8 kDa domain mediate this downstream binding. A helix-hairpin-helix 
motif within this 8 kDa domain interacts with the downstream duplex while another helix-
hairpin-helix motif in the fingers subdomain of the catalytic domain interacts with the upstream 
strands. Structures showing these interactions indicate that the polymerase has bent the DNA 90° 
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at the gap which suggest that these interactions may be stabilizing the DNA in this conformation 
(reviewed in 59).  
Unlike S. cerevisiae, which only has one X-family polymerase (i.e. Pol4), mammals 
possess four: Pol β, Pol λ, Pol µ, and TdT. The presence of four different X family polymerases 
suggests that there may be specialization among them. Pol β and Pol λ possess 5’deoxyribose 
phosphate (5’dRP) lyase activity necessary for their role in base excision repair (BER) 67. 
However, since Pol β lacks a BRCT domain, it is unlikely to contribute significantly to NHEJ 65, 
66. This leaves us with the three polymerases listed above as candidates for mediating gap filling 
during NHEJ.  
Our lab has previously shown that these polymerases exhibit a decreasing gradient of 
template dependence in vitro: Pol λ > Pol µ > TdT 66 (Figure 1.3). Whether these differences 
translate to a specific role for each polymerase in cellular NHEJ has been unclear, except in the 
case of TdT. TdT adds template-independent nucleotides during V(D)J recombination, and its 
expression is limited to pre-B and pre-T cell development 68. Thus, TdT’s role in NHEJ is 
restricted to V(D)J recombination in immune cells. Although Pol λ and Pol µ are active during 
V(D)J recombination, they are also widely expressed. This suggests that they may play roles in 
NHEJ outside of V(D)J recombination 57, 69, 70. 
Pol λ participates in heavy chain gene rearrangements during V(D)J recombination. Pol λ 
deficiency confers shorter heavy chain junctions in mice. However, there are no defects in B cell 
or T cell development, though there is an increased sensitivity to oxidative damage 67, 69. This 
increased sensitivity may be due to Pol λ’s role in BER. Additionally, mouse embryo fibroblasts 
(MEFs) deficient in Pol λ are not radiosensitive 69. Mice deficient in Pol µ have impaired B cell 
development due to excessive deletion during light chain rearrangement 71. They additionally 
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have impaired hematopoiesis and delayed repair of IR-induced DSBs 72. However, the effect Pol 
µ deficiency has on MEFs exposed to IR is less clear 69, 71, 72. Thus, my dissertation work in 
Chapter 3 focuses on determining a role for these two polymerases during general NHEJ. 
1.5.1 Pol λ 
 
Pol λ has been shown to be necessary for gap filling during NHEJ in cell extracts and in 
vitro 63, 64, 66. Of the polymerases implicated in NHEJ, Pol λ has the strictest requirement for 
template strand in vitro. It only efficiently primes synthesis from a paired primer terminus 66. It 
can synthesize across 1 nucleotide gaps as well as larger gaps 63, 73. When dealing with larger 
gaps, Pol λ scrunches the downstream templating base (unpaired base adjacent to downstream 5’ 
phosphate) into a pocket in its catalytic domain. By flipping this base into its scrunch pocket, it 
can synthesize across from each template base, sequentially. This “scrunch” pocket is composed 
of L277, H511, and R514, which are conserved across vertebrate Pol λ homologues but not the 
other X family polymerases. Mutation of these residues reduces the activity of Pol λ on gaps 
longer than 1 nucleotide 73. Thus, Pol λ may specifically promote NHEJ on ends that have 
aligned to generate gaps longer than 1 nucleotide – a possibility that I explore in Chapter 3. 
1.5.2 Pol µ 
 
 Pol µ, unlike Pol λ, is capable of priming synthesis from an unpaired primer terminus 66, 
70, 74. It can bridge ends by extending from the overhang of one end and then using the overhang 
of the other end as a template. There are at least two structural elements which underlie this 
ability. The first is an extended loop between β3 and β4 strands in the palm subdomain (Loop1). 
This loop is longer in Pol µ than Pol λ and has been suggested to act as a template surrogate 66, 75. 
Deletion of this loop abrogates Pol µ’s ability to prime synthesis from an unpaired terminus but 
not on a gapped duplex substrate 66, 75. Additionally, a residue in Pol µ’s active site, H329, may 
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contribute to its ability to extend from an unpaired primer terminus in cells. It contributes to the 
proper positioning of the primer terminus and incoming dNTP. An alanine substitution at this 
residue reduces Pol µ’s activity on a substrate with an unpaired primer terminus while having 
little impact on a substrate with a paired primer terminus in vitro 76. In Chapter 3, I assess the 
extent to which the substrate specificities of Pol λ and Pol µ during NHEJ observed in vitro 
extend to cellular NHEJ. 
  
 9 
Table 1.1: End processing factors 
*HUGO gene nomenclature: XRCC5,XRCC6 (Ku80, Ku70), X-ray repair complementing defective repair in Chinese 
hamster cells 5/6; PRKDC, protein kinase, DNA-activated, catalytic polypeptide; LIG4, ligase IV, DNA, ATP-
dependent; XRCC4, X-ray repair complementing defective repair in Chinese hamster cells 4; NHEJ1 (XLF), 
nonhomologous end-joining factor 1; APLF, aprataxin and PNKP like factor; PNKP, polynucleotide kinase 3'-
phosphatase; APTX, aprataxin; TDP1, tyrosyl-DNA phosphodiesterase 1; TDP2, tyrosyl-DNA phosphodiesterase 2; 
POLM, polymerase mu; POLL, polymerase lambda; DCLRE1C (Artemis), DNA cross-link repair 1C; SETMAR 
(Metnase), SET domain and mariner transposase fusion gene; MRE11/RAD50/NBN, meiotic recombination 11 
homolog/RAD50 homolog/nibrin (Nbs1); WRN, Werner syndrome. 
 
 
CORE FACTORS 
Factor* Activity 
XRCC5, XRCC6 (Ku) 
 
5’dRP (deoxyribose-phosphate)/AP (apurinic/apyrimidinic) lyase; 
precisely removes near-terminal abasic sites at 5’ termini 78, 79 
 
PROCESSING FACTORS 
Factor* Activity 
APLF 
Histone chaperone 80  
3’-5’ exonuclease, endonuclease 81, 82 
 
PNKP Removes 3’ phosphates and phosphorylates 5’ hydroxyls 
83 
 
APTX Removes 5’-adenylate adducts 
84 
 
TDP1 Removes Top I adducts 
85, 3’ deoxyribose fragments 86, 87, 88 
 
TDP2 Removes Top II adducts 
89 
 
POLM (Pol µ) Fills in gaps when ends align with no complementarity 
66 
 
POLL (Pol λ) Fills in gaps when ends are partly complementary 
63, 66 
 
DCLRE1C (Artemis) Endonuclease, 5’-3’ exonuclease 
90 
 
SETMAR (Metnase) Endonuclease/exonuclease, histone methylase 
91 
 
MRE11/RAD50/NBN 
(MRN) 
3’-5’ exonuclease, endonuclease 92, 93 
 
WRN 3’-5’ exonuclease 
94, 95 and 3’-5’ helicase 96 
 
Table 1.1: End processing factors 
Listed are end processing factors associated with NHEJ and their specific activities. Originally 
appeared in 30, 31. 
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Figure 1.1: NHEJ mechanism  
NHEJ is initiated by the recognition of the Ku heterodimer. Ku then recruits DNA-PKCS. 
Following end synapsis, the LIG4/XRCC4/XLF complex is recruited and the ends are ligated. 
Represented here is the NHEJ core machinery (Ku, pink rings, DNA-PKcs, light purple, Ligase 
IV, light blue) in complex with an XRCC4/XLF filament (orange/green). 
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Figure 1.2: Strategies for resolution of DSBs with complex ends by NHEJ 
 NHEJ employs three strategies for resolving damage (red line and starbursts) at ends.  After 
assembly of core factors and alignment of broken ends, the core complex can attempt low 
fidelity ligation, or rearrange the complex and recruit end processing enzymes to remove 
damaged nucleotides and/or synthesize across gaps. Newly synthesized and incoming 
nucleotides are shown (blue). NHEJ may fail and the DSB ends may be resected to initiate HR or 
Alt-EJ. NHEJ may employ these strategies hierarchically. The choice and transition from one 
strategy to the next is likely determined by the complexity of damage at the ends. The NHEJ core 
complex is shown as described in Figure 1.1. Originally appeared in 31. 
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Figure 1.3: Three members of X family polymerases implicated in NHEJ  
(a) These family X polymerases possess a BRCA1 C-terminal (BRCT) domain (orange) an 8 
kilodalton (8 kDa) (green) and a catalytic domain (yellow). (b) The mammalian Family X 
polymerases have activity with decreasing requirement for complementary sequence (orange) 
opposite primer (cyan) and incoming nucleotide triphosphate (red). Template strand (green) and 
downstream strand (purple) are also shown. Originally appeared in 31. 
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CHAPTER 2: THE FIDELITY OF THE LIGATION STEP DETEREMINES HOW ENDS 
ARE RESOLVED DURING NONHOMOLOGOUS END JOINING1 
 
2.1 Introduction 
 
DNA double strand breaks (DSBs) arise spontaneously, after exposure to DNA damaging 
agents, and are also normal intermediates in meiosis and V(D)J recombination. If misrepaired or 
unrepaired they can lead to cellular cytotoxicity and premature cellular senescence, and at the 
organismal level developmental defects – including immunodeficiency and neurodegeneration – 
as well as a predisposition to cancer (reviewed in e.g. 1). A robust nonhomologous end joining 
pathway (NHEJ) is essential for mitigating these defects, but is considered error-prone.  
This pathway begins with the recognition of broken ends by the Ku heterodimer (Ku70 
and Ku80). Ku subsequently recruits the DNA-dependent protein kinase catalytic subunit (DNA-
PKCS) as well as a ligase complex. The ligase complex includes the DNA ligase IV (LIG4) 
catalytic subunit, as well as XRCC4 and the XRCC4-like factor (XLF/Cernunnos) (reviewed in 
2). The only essential step in NHEJ is the rejoining of at least one strand of the double strand 
break, via ligation of 5’ phosphate and 3’OH strand break termini. However, DSBs in vivo often 
have complex ends, where the structure of aligned ends does not allow for straightforward 
juxtaposition of strand break termini. Examples include ends with damaged and adducted 
nucleotides, as well as mispairs, gaps, hairpins, and flaps. 
                                                
1 Waters CA, et al. The fidelity of the ligation step determines how ends are resolved during  
nonhomologous end joining. Nat Commun 5, 4286 (2014). 
 
 22 
In vitro studies have determined that the ligation step in NHEJ can remain active even 
with difficult to align termini 3-7, and further identified XLF as important co-factor in facilitating 
the ability to ligate such ends 8,9.  However, the full extent of flexibility of the ligation step in 
bypassing terminal distortions has not been systematically characterized. It is especially unclear 
how significant the ability to directly ligate complex ends is in the context of cellular NHEJ, and 
if bypass is significantly more effective for classically defined NHEJ, relative to other end 
joining pathways (Alt-EJ). 
Ends can also be processed by a variety of polymerases and nucleases before ligation, in 
yeast (e.g. 10-13) and in mammalian models (e.g.14-23), and much progress has been made 
identifying and characterizing these activities. Products of cellular NHEJ are often associated 
with extensive heterogeneity, for example those generated during V(D)J recombination24, and 
after sustained expression of targeted endonucleases (e.g. I-Sce I, CRISPR or TALEN) (e.g. 
25,26). This heterogeneity has led to characterization of NHEJ as error-prone, with a stochastic 
component contributing both to whether ends are processed before ligation, as well as how.  
Ends can thus be resolved either by direct ligation, bypassing the need for processing, or 
processed first, but how well the initial structure of an aligned end-pair determines the balance 
between these two alternatives is still unresolved (reviewed in 27-30).  Here we address this 
question with a series of substrates that systematically increases the predicted barrier to ligation 
in increments, and determine in cells how this impacts the balance between low-fidelity ligation 
of a pair of ends versus ligation of these ends after they have first been processed. Our results 
outline the extent to which NHEJ’s ligation step is capable of bypassing mispairs and damage, 
and indicates that the path to resolution employed during NHEJ is well-tailored to the needs of 
different substrates. 
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2.2 Methods 
Substrates and NHEJ assays 
 
Substrates were made by amplifying a 300 bp fragment using the primers described and 
digested with BsaI or BstXI to generate the appropriate end structure. Additionally, each 
substrate’s “head” was made identical to that of its “tail” (Fig. 2.1a), ensuring the paths to 
resolution for all three possible aligned end-pairs (head to head, tail to tail, and head to tail) are 
equivalent.  
Primer sequences were: 
CTAG3’ : 5’ – GTGGTCCACCTAGATGGCTTAGCTGTATAGTCA 
      5’ – GCCGACCAGCTAGATGGCACACCCATCTCA 
TGCG3’ : 5’ – CAAGTGGTCCACCGCAATGGCTTAGCTGTATAG 
    5’ – GCCGACCAGCGCAATGGCACACCCATCTCA 
TCGC3’ : 5’ – CAAGTGGTCCACGCGAATGGCTTAGCTGTATAG 
    5’ – GCCGACCAGGCGAATGGCACACCCATCTCA 
AGCG3’ : 5’ – CAAGTGGTCCACCGCTATGGCTTAGCTGTATAG 
    5’ – GCCGACCAGCGCTATGGCACACCCATCTCA 
5’GATC : 5’ – CAAGTGGTCTCCGATCATCGCTTAGCTGTATAG 
   5’ – GCCGAGGTCTCAGATCATCACACCCATCTCA 
5’GCGT : 5’ – CAAGTGGTCTCCGCGTATCGCTTAGCTGTATAG 
     5’ – GCCGAGGTCTCAGCGTATCACACCCATCTCA 
5’CGCT : 5’ – CAAGTGGTCTCCCGCTATCGCTTAGCTGTATAG 
    5’ – GCCGAGGTCTCACGCTATCACACCCATCTCA 
5’GCGA : 5’ – CAAGTGGTCTCCGCGAATCGCTTAGCTGTATAG 
     5’ – GCCGAGGTCTCAGCGAATCACACCCATCTCA 
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5’GOATC : 5’ - AGTGGTCTCCGOATCCTCGCTTAGCTGTATAGTCA 
      5’ - GGTATGTTGGTCTCAGOATCCTCACACCCATCTCAGAC 
Substrates for in vitro assays were labeled by amplification in the presence of αCy5-dCTP 
(GE Healthcare), and cartridge purified (Qiaquick PCR Purification, Qiagen). Human Ku, 
XRCC4-LIG4 complex, and XLF were overexpressed in Hi-5 cells. Cell pellets were extracted, 
lysed by sonification, clarified, and loaded onto a His-TRAP column (GE biosciences). Bound 
protein was eluted by a step- increase to 350mM imidazole before loading onto a Mono-Q 
column (GE biosciences) and eluted with a linear gradient of KCl. Fractions encompassing the 
peak of eluting protein were pooled, flash-frozen in liquid nitrogen, and stored at -80° C 22,54. 
Human polymerase l was purified after expression in bacteria, and was the gift of Dr. Tom 
Kunkel. In vitro NHEJ reactions were initiated by mixing 10 nM Ku, 20 nM XRCC4-LIG4 
complex, or 100 units T4 DNA ligase (NEB), 2 nM polymerase, and 2 nM DNA substrate in a 
buffer with 25 mM Tris-Cl (pH7.5), 1 mM DTT, 150 mM KCl, 4% glycerol, 40 µg/ml bovine 
serum albumin, 0.1 mM EDTA, 7.5% polyethyelene glycol (MW 8,000 kDa), 100 µM of each 
dNTP, 5 mM Mg2+, and 100 ng supercoiled DNA. All reactions were carried out at 37 °C for 10 
minutes, stopped by addition of EDTA and SDS, extracted with a 1:1 mixture of phenol and 
chloroform, and resolved on a 5% native PAGE gel. Junctions were characterized by 
amplification with primers specific for head to tail junctions (5’ – 
CTTACGTTTGATTTCCCTGACTATACAG & 5’ – GCAGGGTAGCCAGTCTGAGATG), 
and digested with BstXI as diagnostic for direct joining, and AfeI (AGCG3’) or FspI for 
(TGCG3’) as diagnostic for synthesis and ligation. Digestion products were visualized using a 
Typhoon Imager and quantified using ImageQuant (GE Healthcare).  
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Except for the 5’GOATC substrate, substrates used in cellular NHEJ assays were generated 
by amplification, subcloned into the pCR2.1-TOPO TA vector (Invitrogen), and sequenced. 
Purified plasmid DNA was then digested using the appropriate restriction enzyme, and the 
fragment purified by agarose gel electrophoresis. Accuracy of end structures after digestion was 
further validated at high resolution by visualization of both strands of one end of the substrate in 
the context of a short (48 bp) sub-fragment on a denaturing 7% polyacrylamide gel, after serial 
treatment of gel purified substrate with Hinf1, phosphatase, and T4-kinase, in the presence of 
γ32P-ATP (Fig. 2.9a). 5’GOATC was generated as described for in vitro assays, except without 
αCy5-dCTP label.  
HCT116 and its LIG4 deficient variant were cultured in McCoy’s 5A media with 10% fetal 
calf serum and human melanocyte cells (NHM) cultured in DermaLife M medium (Lifeline Cell 
Technology). Mouse dermal fibroblasts deficient in Ku70 and p53 were the gift of Dr. P. Hasty 
(UT San Antonio), complemented by expression of mouse Ku70 cDNA or empty vector 
(pBABE-puro), and grown in Dulbecco’s Modified Eagle Medium with 10% fetal calf serum and 
2 µg/ml puromycin.  20 ng of the purified, validated substrate and 600 ng of pMAX-GFP were 
introduced into 2x105 of these cells by electroporation (Neon, Life Technologies) using a 10-µL 
chamber and one 1530 V, 20 ms pulse (HCT116); three 1500 V, 10 ms pulses (NHM); or one 
1350V, 30 ms pulse  (Ku70-/-), then incubated in 300 µL of the appropriate media without 
antibiotic at 37°C for 5 hours or 15 minutes as indicated. Under these conditions 81% (± 4%) of 
HCT116 cells express GFP and 88% (± 3.6%) exclude propidium iodide after 5 hours, with 
results indistinguishable for both parental cells and LIG4-/- variants. Electroporations were 
performed in triplicate, then repeated in triplicate for each substrate and cell line pair on a second 
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day. A single electroporation (out of the 138 analyzed in Fig. 2.2 and 2.6) was excluded from 
analysis due to failed electroporation or sample loss during recovery.  
Cells were then washed with phosphate buffered saline (PBS) before harvesting of total 
cellular DNA  (QIAmp, Qiagen) except for the experiment described in Fig. 2.10a, where cells 
had to be lysed without washing. Junctions in recovered DNA were assessed by quantitative real- 
time (PCR), using an ABI 7900HT (Applied Biosystems), primers that amplify head to-tail-
junctions (see above), and SYBR green detection. These primers will amplify junctions having 
deletions up to 13 and 12 nucleotides from left and right flanks, respectively (25 nucleotides 
total) for 5’ overhang containing (BsaI generated) substrates. For 3’ overhang substrates we 
added an additional two nucleotides in the right flank to allow for inclusion of the BstXI site; the 
same primers thus amplify junctions up to 27 nucleotides for these substrates. Previous work 
indicates this is sufficient to sample products generated by canonically defined NHEJ (e.g. 26,55).  
We validated amplification efficiency and ensured quantification was performed in a linear 
range by including a standard curve (Fig. 2.9b) in parallel with experimental samples. The 
standard curve was generated by serially diluting an oligonucleotide model amplicon (product of 
5’GATC substrate) into DNA harvested from a mock transfection. We estimate, using serial 
harvests after electroporation, that joining accumulated to a maximum within an hour (Fig. 
2.10a). Using the standard curve we further estimated the average accumulation of product 
molecules for all 5-hour experiments in HCT 116 cells described here was 60/cell (s.e.m. +/- 
6.1). Additional experiments indicated product increases proportionately with increased 
substrate, thus repair capacity was not saturated under these conditions. We conclude the rate and 
capacity of NHEJ measured here is comparable to that observed for repair of chromosome breaks 
after exposure of cells to 2 Gray of ionizing radiation 56,57. 
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In Fig. 2.2 we limit analysis to pairwise comparison of joining efficiencies in wild type 
versus LIG4 deficient cells for each individual substrate. For the experiment described in Fig. 
2.6a only, all three substrates were introduced into both cell lines in triplicate on the same day in 
parallel (then this was repeated on a second day), allowing us to explore relative joining 
efficiency when comparing different substrates. Joining efficiencies for Fig. 2.6a are thus 
expressed relative to that observed for undamaged 5’GATC after introduction into wild type 
cells.  
Sequencing  
 
Template DNA for each sequencing library was pooled from the three independent 
electroporations performed on a single day. We amplified 5x105 input junction molecules 
(determined by qPCR) using Phusion DNA polymerase (NEB) and variants of the qPCR primers 
that have 6-nucleotide barcode sequences appended to their 5’ ends for 21 cycles (Fig. 2.9c). 
15.5 ng of amplified DNA from each amplified library was then pooled again in groups of 9-11 
libraries (7 groups total), 5’ phosphorylated, treated to add dA to 3’ termini, and then ends 
further appended by ligation with an adaptor for paired end sequencing (Illumina). Free adapter 
was removed by gel purification. A final pool of all gel purified libraries (109 separately indexed 
libraries for the run used here) was then amplified with adapter-specific primers for 10 cycles, 
purified (Agencourt Ampure XP, Beckman Coulter) and equal amounts (180 ng) of DNA from 
each group of libraries were combined and submitted for a 2X 80bp (i.e. paired end run) 
sequencing run (MiSeq, Illumina) with a phiX174 DNA “spike-in” to ensure matrix and phasing 
intensity calibration parameters could be accurately estimated.   
Reads with PhiX 174 DNA were removed. Paired ends reads were then merged and libraries 
de-indexed using Genomics workbench v6.0.3 (CLC-Bio). A proportion of improperly de-
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indexed reads in each library were identified by exact matches to the most frequent reads from 
other libraries and excluded, leaving 455,082 reads distributed over the 33 libraries (excluding 
controls) discussed here.  
We assessed sample diversity after amplification using a control amplicon with an 
embedded degenerated tetramer, using the same input number of control amplicon molecules as 
experimental samples (5x105). We recovered all 256 sequence combinations of the degenerate 
tetramer in 18883 reads, with representation of each sequence (number of reads for each 
sequence/total reads) distributed as shown (Fig. 2.9d).  
Substitution error intrinsic to sample processing was assessed using another control library, 
prepared by in vitro ligation of 5’GATC substrate with T4-ligase.  The mean substitution 
frequency over the length of this product was 1.2X10-3, +/- 9X10-4 (s.d.). The frequency of single 
nucleotide substitutions in reads from experimental samples was not significantly greater than 
the control, regardless of whether the position assessed was at the junction or in flanking DNA 
(Fig. 2.10b). Analysis of experimental samples is thus restricted to counting exact matches to a 
test set of sequences that includes all combinations of terminal deletions from ends that can be 
both amplified by the primers described above, and distinguished as a unique sequence (this set 
is comprised of 165 sequences for AGCG3’; the number differs slightly for different substrates, 
according to variable presence of some sequence identities in the two flanks).  We additionally 
included in the set junctions consistent with definitive “N-additions” as identified by those reads 
with insertions of random length and sequence from intact ends. Notably, N-additions defined 
this way were detected only when using 5’ overhang containing substrates; even then, they were 
rare (<0.05% of recovered junctions), and almost exclusively observed after 5 hour incubations 
in HCT 116 cells.  Finally, we compensated for reductions in the counts of reads of exact 
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matches for each sequence due to processing-dependent substitution error according to the 
formula y= x(1-(a*n)), where y is the corrected count, x is the experimentally observed count of 
exact matches,  a=1.2X10-3  (average substitution frequency in control library), and n=length of 
tested sequence.  
Analysis of joining with GO termini 
 
 GO-containing templates amplify less efficiently than undamaged templates (Fig. 2.9b). 
Reduced amplification efficiency is thus expected to result in underestimation of retained GO by 
a factor of 2 as determined by both techniques described below. 
The frequency of A incorporation opposite GO (transversion mutation) during amplification 
was determined to be 89.0% under our sample preparation conditions, using a control library 
generated by in vitro ligation of the 5’GOATC substrate with T4 DNA ligase. Retention of GO in 
junctions from cells was thus estimated by dividing observed transversion containing junctions 
by 0.89. The frequency of observed G containing junctions was then reduced by the difference 
between estimated GO and junctions with transversions. 
We also independently assessed presence of GO in junctions by probing the sensitivity of 
product to formamidopyrimidine [fapy]-DNA glycosylase (Fpg), an enzyme that incises at 8-
oxoG (Fig. 2.11b,c). We pre-digested qPCR reactions assembled as described above with 0.4 
units of Fpg (New England BioLabs) for 1 hour at 37°C (or mock digested) before starting the 
standard qPCR cycling protocol. We defined the dynamic range of this assays using control T4 
ligated GATC and GOATC substrate. Control 5’ GATC containing junctions were thus resistant 
to Fpg (112%, +/-7, relative to undigested), while control GOATC containing junctions were 
sensitive (10.2%, +/-0.1%, relative to undigested). This range was sufficient to confirm the 
majority of cellular GOATC containing junctions were fpg sensitive, and this proportion 
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decreases with time in the cell. However, the significant background resistance (10.2%) using 
pure model product indicates the low levels of Fpg resistant product in our samples is a less 
accurate estimation of GO retention than is possible with sequencing analysis. Additionally, this 
technique does not distinguish between the different causes for Fpg resistance (precise 
replacement with undamaged G, versus deletion of overhang). Interpretations in the results 
section thus focus on results of sequencing analysis. 
Statistical methods  
 
One way ANOVA tests with p-values adjusted by the Bonferonni method (Fig. 2.6a), or 
Student’s T-tests (Fig. 2.11a) were used to compare the continuous variables between groups, as 
appropriate. Proportions of interest (Table 2.1) were compared via logistic regression models, 
with adjustment for extra-binomial variation as described in 58. This method allows and adjusts 
the estimates and the standard errors for variation that exceeds that of the binomial model. This 
extra variation can be due to correlation between the outcomes of the individual reads, each read 
being a classification, for example, into either direct or not. Analyses were done using GraphPad 
Prism, GraphPad Software, San Diego CA and SAS version 9.2, Cary NC. Proportions were 
compared using a logistic regression model, with adjustment for extra-binomial variation. 
2.3 Results 
Substrates to assess the significance of ligation fidelity to NHEJ 
 
A series of substrates were designed to investigate how the path to resolution in NHEJ is 
influenced by gradually increasing the barrier to the ligation step. Each substrate has partly 
complementary overhangs that generate terminal mispairs (e.g. G:T in Fig. 2.1a i,b) when 
aligned. The complementary portion of the overhang was then kept constant for different 
substrates, and only the terminal mispair varied; for example 3’ terminal G:T versus G:A as 
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noted in Fig. 2.1b,c. All substrates can thus be resolved in one step by a ligation (termed direct 
ligation, or bypass) as described in Fig. 2.1a i.  
The ends of these substrates can also be processed before ligation, allowing assessment of 
the extent to which engagement of end processing is responsive to different barriers (i.e. mispairs 
or damage) to the ligation step. However, to address if the exact nature of end processing could 
also be influenced by initial end structure, all substrate variants allow for a second alignment that 
generates a 2-nucleotide gap, and which requires only fill-in synthesis before ligation (Fig. 2.1a 
ii). This latter possibility was intended as an alternate path that is intermediate in complexity 
between direct ligation (Fig. 2.1a i) and paths where the end is first remodeled by a nuclease 
step, including resolution by “editing” (Fig. 2.1a iii, iv; discussed in greater detail below).  
The utility of these substrates was first tested in vitro, using an example with TGCG3’ 
overhangs. Direct ligation of this substrate would require “bypass” of a G:T 3’mispair, as 
depicted in the cartoon panel of Fig. 2.1b. The substrate was incubated with purified Ku, 
XRCC4-LIG4 complex, XLF, and DNA polymerase λ, thus only two of the paths described in 
Fig. 2.1a - ligation or synthesis and ligation - are possible (Fig. 2.1a i, ii). Head-to-tail ligation 
products were then characterized by digestion of amplified products with restriction enzymes 
that are diagnostic for each path (Fig. 2.8a).  33% of TGCG3’ ligation products were formed via 
direct ligation, with the remainder attributable to synthesis and ligation (Fig. 2.1b, right panel). 
Omission of either the polymerase or synthesis precursors reduced joining efficiency (Fig. 2.1b, 
left panel; Fig. 2.8b), indicating direct joining with a G:T 3’ terminal mispair is unable to fully 
compensate for the absence of a possible synthesis-dependent resolution. NHEJ’s ligase complex 
is thus only partly able to bypass this mispair. Moreover, only trace levels of joining were 
observed when T4-DNA ligase was substituted for XRCC4-LIG4 complex, whether the 
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polymerase was included or not (Fig. 2.8c). Therefore, ligase activity per se, i.e. as provided by 
T4 ligase, was not sufficient for either of the resolutions mediated by the XRCC4-LIG4 complex 
(bypass of the terminal mispair by direct ligation or polymerase-dependent resolution).    
The ability of ligases to tolerate mispairs can depend on how similar the mispair width 
(e.g. C1’-C1’ distance) is to that of matched base pairs 31. We therefore substituted the G:T 
purine:pyrimidine mispair with the bulkier G:A purine:purine mispair (AGCG3’; Fig. 2.1c). 
Although overall ligation was comparable (Fig. 2.1b cf. 2.1c, left panels), the proportion of direct 
ligations was reduced to 4% with this substrate (Fig. 2.1c, right panel), with the fraction of 
synthesis-dependent resolutions increasing to compensate. Accordingly, there was less joining of 
AGCG3’ than was observed with TGCG3’ when polymerase λ was omitted (Fig. 2.1b cf. 2.1c, 
left panels). These substrates thus identify a variable ability of NHEJ to bypass terminal mispairs 
consistent with previously described patterns of ligase fidelity, and show how a specific 
processing-dependent resolution path is engaged as a compensating mechanism. 
Ability of cellular NHEJ to bypass terminal mispairs  
 
Is there a similar balance between low fidelity ligation and end processing in cellular 
NHEJ? Additionally, NHEJ in cells employs a variety of processing enzymes – including 
nucleases - in addition to polymerase activity, thus ends may be processed by diverse means. 
These DNA substrates were consequently introduced into a human cell line (HCT 116), and 
joining was characterized both in terms of efficiency, by quantitative PCR (qPCR) of head-to-tail 
products, as well as product structure, by sequencing (Fig. 2.2a and Fig. 2.9). We used conditions 
that resulted in a rate and capacity of substrate joining comparable to that observed for 
chromosomal repair after 2 Gray of ionizing radiation (Fig. 2.10a and methods). Joining of all 
substrates under these conditions was primarily mediated by classically defined NHEJ, as 
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reflected by the >10 fold defect in joining efficiency observed in LIG4-/- cells 32 relative to its 
isogenic matched wild type parent (Fig. 2.2b). We additionally confirmed that a diverse product 
spectrum was maintained through the amplification and sample processing steps required for 
sequencing analysis (Fig. 2.9d).  
The panel of substrates was also expanded to obtain a more comprehensive picture of the 
contribution of low fidelity ligation to NHEJ. Substrates with fully complementary overhangs 
(no terminal mispair) were added to assess the background of end processing observed when 
there is no barrier to ligation. An end structure with a terminal pyrimidine:pyrimidine mispair 
(C:T) was also included (TCGC3’). Finally, parallel versions of these 3’ overhang substrates 
with opposite overhang polarity (5’) were generated.  
As expected, a fully complementary 3’ overhang was rarely processed before ligation; 
88% of the recovered sequences were products of direct ligation when using the CTAG3’ 
substrate (Fig. 2.2c). Directly ligated product then accounted for 28% of recovered sequences for 
the TGCG3’ substrate (G:T mispair), 12% for TCGC3’ (C:T mispair), and 6% for AGCG3’ (G:A 
mispair) (Fig. 2.2c). The proportion of directly ligated product was thus reduced upon inclusion 
of a mispair, and then reduced further with increasing predicted severity of the terminal mispair 
(see Table 2.1 for statistical analyses of significance). The proportions of direct joining observed 
for TGCG3’ and AGCG3’ during cellular NHEJ were also similar to the proportions observed in 
in vitro reactions with these substrates (Fig. 2.1b,c).  
A similar progressive reduction in direct ligation was observed for the panel of 5’ 
overhangs, from 94% (5’GATC; paired), to 85% (5’GCGT; G:T mispair), to 9% (5’GCGA; G:A 
mispair) (Fig. 2.2c). However, mispairs at the terminus of a 5’ overhang were more easily 
tolerated than the comparable mispair at the terminus of a 3’ overhang (p<0.0001, Table 2.1). 
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This was most apparent for the G:T mispair, where directly ligated products were 3-fold more 
frequent when the mispair was within a 5’ overhang, relative to a 3’ overhang.  Cellular NHEJ 
thus favors direct ligation of terminal mispairs (ligation “bypass”) when possible.   
Effects of terminal mispairs on end processing 
 
If ends cannot be ligated directly, there is great flexibility in how they can be processed 
during cellular NHEJ – any of the paths described in Fig. 2.1a could be employed and chosen at 
random, leading to heterogeneity in products. Instead, decreasing ability to bypass different 
terminal mispairs in different substrates typically resulted in progressively increased recovery of 
the single junction sequence that is indicative of synthesis and ligation (Fig. 2.1a ii and 2.2c; 
Table 2.1). Strikingly, the redirection of resolution path was often seamless; reduction in ability 
to resolve by direct ligation often resulted in a near-equal increase in resolution by synthesis and 
ligation (e.g. Fig. 2.2d,e). When assessing synthesis, substitution error at sites of cellular 
polymerase activity was less than 2X10-3, and indistinguishable from that attributable to sample 
processing (Fig. 2.10b). Additionally, both nucleotides of the 2-nucleotide gaps were usually 
(>98%) filled-in (Fig. 2.10c,d).  
Resolutions associated with deletion were typically rare. For the majority of substrates, 
we recovered over 40 different junction sequences with terminal sequence deleted, but they 
accounted for in sum 12% or less of products (Fig. 2.2c). Substrates that both had 3’ overhangs 
and can align with a terminal mispair were the exception: resolutions after deletion were over 
twice as frequent for this class of substrates, relative to any other substrate (Fig. 2.2c).  The 
observed increase in deletions was further largely limited to a specific kind of deletion, where the 
sequence lost was restricted to one or both of the single stranded DNA overhangs (ssDNA 
deletion; Fig. 2.3a, b). Therefore, a class of ends that are especially poorly bypassed by direct 
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ligation (3’ terminal mispairs; Fig. 2.2c) triggers use of an alternate (third) path for their 
resolution, where end structure is more generally altered, or remodeled, by activity of a ssDNA 
endo/exo nuclease. Artemis is a likely candidate for this activity 33,34(see also discussion).  
Notably, the most frequent junction with overhang-limited deletion (ssDNA deletion; Fig. 
2.3c) can be readily explained as a product of a path that is also alignment directed and employs 
only a single extra step, relative to the other paths already discussed. Editing (Fig. 2.1a iii) 
requires 1) removal of the terminal nucleotide by a nuclease, 2) alignment of the remaining 
overhang and fill in of the resulting 1-nucleotide gap by a polymerase, followed by 3) ligation. 
Consistent with this inferred 3-step pathway, the recovery of the edit product, as well as most of 
the other deletions, are severely reduced in cells deficient in both NHEJ polymerases (Pol µ and 
Pol λ; C.A.W., J.M.P., and D.A.R, unpublished data). Inasmuch as this resolution path involves 
replacement of a terminal mispair with a complementary nucleotide, it is analogous to the editing 
of terminal mispairs after polymerase misincorporation (see also the Discussion, below). Editing 
is guided by alignment of the same amount (2 bp) of complementary sequence in the overhangs 
as the previously discussed paths (Fig. 2.1a), and thus can be considered equally favorable. 
Editing is consequently distinguished from “other deletions” in subsequent figures. This is also 
rationalized by the observation that other deletions can be slower to accumulate than junctions 
with editing, as discussed below (Fig. 2.4b,c).  
Deletions that extended into flanking double stranded DNA (dsDNA deletions) were in 
total rare, though deletions guided by fortuitous sequence identities (microhomologies; Fig. 
2.3a,b ; 2.4c) were enriched amongst these, as has been previously observed 14. 
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Changes in resolution path over time  
 
We describe above how the identity of a terminal mispair affects the balance between 
direct ligation versus ligation after end processing, and were interested in determining whether 
this balance changes over time. Products were therefore recovered after 15 minutes in cells and 
results compared to our previous data, where the products were recovered after 5 hours. This 
comparison was performed using both a substrate (5’GCGT) that favors resolution by direct 
ligation, as well as a substrate (AGCG3’) that favors a resolution path requiring a processing 
step.  
Resolution paths for 5’GCGT ends changed very little with prolonged time in cells (Fig. 
2.4a). In contrast, the primary mechanism for resolution of AGCG3’ ends – synthesis and 
ligation - decreased over time (8.5%), with deletions increased to compensate (Fig. 2.4b). 
Resolutions by synthesis and ligation were thus surprisingly under-represented upon extended 
incubation, even when compared to resolutions by direct ligation. We conclude the need to 
perform an additional enzymatic step (synthesis) was not rate-limiting, at least for this substrate.  
As noted above, direct ligation, synthesis and ligation, and editing are all guided by the 
same amount of complementary sequence in the overhang, and are thus equally favored (Fig. 
2.1a). Together, they account for the clear majority of products after 15 minutes in cells for both 
substrates (99% and 94% for 5’GCGT and AGCG3’, respectively; Fig. 2.4c). Remaining 
products were associated with greater amounts of deleted sequence, and included both 
heterogeneous and microhomology-determined products. This less accurate class was initially 
rare and increased slowly, though rates differed depending upon substrate. Importantly, the 
limited product heterogeneity observed even for the 15-minute sample was not a function of 
sampling error. An equivalent number of input template molecules (determined by qPCR) were 
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used for all four libraries for each substrate (two replicates of each timepoint), as well as the 
library that validated ability to sample diverse product spectra (Fig. 2.9d).  
Changes in resolution path in different cell types 
 
To discern to what extent our results were specific to the HCT-116 cell line, we next 
assessed how these substrates were resolved by performing parallel experiments with selected 
substrates in a primary human melanocyte culture (passage 8; Fig. 2.5a). The trends in mispair 
tolerance were the same for melanocytes as in HCT 116 cells; direct joining was more frequent 
for a pyrimidine:purine mispair, relative to a purine:purine mispair (93% for 5’GCGT cf. 30% 
for 5’GCGA; Fig. 2.5a, p<0.0001; Table 2.1). The same mispair was also better tolerated in the 
context of 5’ overhangs, relative to 3’ overhangs (93% for 5’GCGT cf. 37% for 3’GCGT; Fig. 
2.5a, p<0.0001; Table 2.1).  
In contrast, cell type significantly altered the balance between resolution paths for a given 
substrate. Bypass or direct ligation of mispairs was more frequently employed in melanocytes, 
relative to HCT 116 cells, for all three of the substrates with partly complementary overhangs 
that were tested (Fig. 2.5b). As with differing substrate, changes in resolution by direct ligation 
due to different cell line were primarily compensated for by a change in resolution by the next-
most-simple path in terms of numbers of steps (synthesis and ligation). 
The ability of cellular NHEJ to bypass terminal damage 
 
The above experiments focused on strand break termini that interfered with ligation 
because they were mispaired. Damaged termini may be qualitatively different, and removed 
regardless of whether they are a significant barrier to ligation. We therefore generated a substrate 
with a terminal 8-oxo-7,8-dihydroguanine (GO), the most abundant base damage generated by 
ionizing radiation 35  and thus expected to be near damage-induced breaks. The overhang was 
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otherwise complementary (5’GOATC), and consequently this substrate assessed the ability of 
NHEJ to tolerate a terminal 5'GO:C damaged pair. 
Wild type cells were equally able to join 5’GATC (5’G:C paired terminus), 5’GCGT 
(5’G:T mispaired terminus) and 5’GOATC (5’GO:C damaged pair terminus) (Fig. 2.6a). LIG4-
deficient cells also retain significant activity on the undamaged, paired terminus (5’GATC), 
consistent with activity of remaining mammalian ligases. However, LIG4-deficient cells were 
much less active in joining ends with terminal distortions, especially when considering the Go:C 
damaged pair (5’G:C cf. 5’GO:C, Fig. 2.6b). Joining of ends with the damaged GO:C pair is also 
specifically and severely reduced in cells deficient in Ku 70 (5’G:C cf. 5’GO:C, Fig. 2.11a). We 
conclude classically defined NHEJ is uniquely effective in joining ends with a terminal GO:C 
pair.  
Oxidized nucleotides, especially 8-oxoguanine, can be targeted for removal. We therefore 
assessed if we could detect GO in product, to determine if GO was bypassed by direct ligation (as 
with G;T mispair) or if GO was replaced with an undamaged G before ligation. GO in product 
was estimated by sequencing analysis, as templates with GO generate characteristic transversion 
mutations 36 after amplification. We further evaluated the frequency of transversion mutation 
opposite GO in template under our conditions using a model template, and employed this 
frequency as a correction factor (see also Methods). A parallel analysis using an enzymatic probe 
for GO in the product was generally confirmatory (Fig. 2.11b,c and methods). Additionally, we 
note that both approaches under-estimate the amount of retained GO, as templates with GO are 
less efficiently amplified (by a factor of 2 under our conditions) than undamaged templates (Fig. 
2.9b). 
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Thus, at least 94% of the products retained GO (“direct ligation”) when recovered after 15 
minutes of incubation in HCT 116 cells (Fig. 2.6b). The frequency of processing for the terminal 
GO:C pair was comparable to an undamaged terminal G:C pair (Fig. 2.2c), and less than even the 
most easily bypassed mispair (5’GOATC cf. 5’GCGT; Fig. 2.6b). Of processing events, GO was 
most frequently replaced with undamaged G, rather than deleted (Fig. 2.6b). Notably, end 
sequence was designed to also allow for an alternate alignment through two terminal 
GO(syn):A(anti) base pairs, generating a 2 nucleotide gap, but less than 0.1% of recovered 
products were consistent with resolution after such an alignment. We conclude NHEJ’s ligation 
step is highly effective in direct bypass of a terminal 8-oxo-7,8-dihydroguanine.   
The frequency of GO replacement was increased after 5 hours, and was approximately 
twice as efficient in melanocytes, relative to HCT 116 cells (Fig. 2.6c cf. 2.6d). It is possible 
replacement precedes NHEJ’s ligation step (Fig. 2.6e), similar to editing of terminal mispairs. 
However, GO:C>G:C replacement in product was significantly delayed (Fig. 2.6c), in contrast to 
observations for mispair editing (G:T>A:T; Fig. 2.4). We therefore favor a model where 
replacement of the damaged nucleotide occurs after NHEJ is complete and is mediated by base 
excision repair. Regardless, such replacement was inefficient – even after incubation for 5 hours, 
over 80% of junctions from HCT 116 cells retained the damaged nucleotide. Classically defined 
NHEJ is thus effective at directly ligating together ends with 5’ terminal 8-oxo-7,8-
dihydroguanine – even though the same substrate severely blocks joining by alternate 
mammalian ligase(s) and pathways active in cells deficient in LIG4 (Fig. 2.6a) or Ku70 (Fig. 
2.11a). 
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2.4 Discussion 
 
We assessed here how well the ligation step during NHEJ can bypass terminal distortion 
during cellular NHEJ, using substrates where terminal distortion was increased in increments. 
We show the ligation step during cellular NHEJ is effective in tolerating a variety of terminal 
mispairs, but especially a damaged base pair, 8-oxo-7,8-dihydroguanine:C (GO:C), expected to 
be frequent at radiation-induced DSBs (Fig. 2c; 6b). In contrast, in cells missing either LIG4 
(Fig. 2.6A) or Ku70 (Fig. 2.11a), joining of ends with terminal GO was reduced over 40 fold 
relative to the undamaged control substrate. The robust joining sometimes observed in LIG4 or 
Ku70 deficient cells has been used to define “Alt-NHEJ” 37,38, thus we conclude DSBs with 
terminal 8-oxo-7,8-dihydroguanine are extremely poor substrates for this pathway.   
 Our results imply the LIG4 holoenzyme (LIG4, Ku, XRCC4, XLF) may act 
effectively as a “translesion” ligase. That is the NHEJ complex could be unique amongst 
mammalian ligase machines in its proficiency in ligating a DSB terminus with GO opposite C 
much as DNA polymerase η is unique amongst mammalian polymerases in its proficiency in 
adding A opposite a thymidine dimer 39. As is the case for translesion polymerases, sustained 
activity on damaged substrates may rely at least in part on structural elements intrinsic to the 
enzyme. Consistent with this idea, a structure of LIG4 identified elements predicted to interact 
with substrate that are unique amongst mammalian ligases, and argued to be significant in 
ligation of distorted termini 40. 
There was nevertheless a wide range in cellular NHEJ’s bypass ability: when challenged 
with varied mispairs, the proportion of direct ligations decreased in decrements from 85% (5’G:T 
mispair), to 6% (3’G:A mispair) (Fig. 2.2c; Table 2.1). Generally, the mispairs that are better 
tolerated during cellular NHEJ are those with width similar to that of a pyrimidine:purine, and 
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which are 5’ of the strand break. This pattern is consistent with that observed for other 
eukaryotic ligases in vitro (Fig. 2.2, Fig. 2.5; see Table 2.1 for statistical tests) 31,41. It is best 
explained if significant LIG4 activity requires it to fully encircle double-stranded DNA flanking 
a strand break and primarily engage the 5’ side, as observed in structures of other mammalian 
ligases 42,43 and in DNA-bound models for LIG4 40.  NHEJ’s ligation step is thus far-removed 
from structure-independence. 
How is the means (or path) for resolving a complex end determined during cellular 
NHEJ? Past studies show resolution of broken ends by NHEJ is guided by alignment of 
complementary sequence in overhangs when present 14; in this study, they accounted for 75%-
98% of junctions (Fig. 2.2c and 2.3b). The substrates described here were further designed such 
that each allows for three such alignment-directed resolution paths - direct ligation, synthesis and 
ligation, and editing – with all three paths guided by an alignment of the same amount of 
complementary sequence (2 nucleotides; Fig. 2.1a). Our results thus speak directly to how 
resolution paths are chosen for different end structures, given initial alignments that are equally 
favorable.  
As noted above, ends are resolved by one-step direct ligation when terminal distortion is 
sufficiently mild. However, as direct ligation is made more difficult, reductions in direct ligation 
are almost entirely accounted for by increases in the next most-simple resolution, the two-step 
synthesis and ligation. This is apparent both when comparing different 5’ mispairs (Fig. 2.2e), as 
well as different 3’ mispairs (Fig. 2.2d).  
However, there is a consistent difference in how ends are processed when comparing 5’ 
vs. 3’ mispairs; deletion is at least 2-fold more frequent for substrates of the latter class, 
regardless of cell type (Fig. 2.3b). We suggest deletion is important primarily in contexts where 
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both polymerase and ligase activity are either very inefficient or blocked. Such contexts include 
3’ mispairs, as described here, but presumably other blocking lesions as well (e.g. 3’ 
phosphoglycolate). Poor tolerance of 3’ mispairs by the other mammalian ligases has been 
rationalized previously as an advantage in the context of excision repair pathways (base exision 
and nucleotide excision repair)44, as a means to promote ability to proofread or edit the 
misincorporation errors from an earlier polymerase step.  Notably, the most abundant deletion 
observed for 3’ mispairs is consistent with such a process (edit; Fig. 2.1a; 2.3b,c). Thus, 
increased deletion at 3’ terminal mispairs in NHEJ has a mechanistic basis – as a group they are 
the least well-tolerated by the ligase – but possibly also a biological rationale, as a means for 
correcting frequent polymerase misincorporation error.  
We conclude the mechanism used for resolving mispaired or damaged ends during 
cellular NHEJ is adapted to the specific aligned end-pair. Our results further argue this is 
achieved by giving precedence to resolution paths with the fewest number of enzymatic steps – 
direct ligation (one step) is favored over synthesis and ligation (two steps), which is favored over 
more complex paths that include deletion (typically one or more excision steps, followed by 
synthesis and ligation; at least three steps, e.g. edit). This organization of resolution path is best 
explained if there is also a hierarchy in attempted DNA transaction (Fig. 2.7). Direct ligation is 
attempted first, and synthesis attempted next if ligation fails, and excision restricted to specific 
contexts where end structure requires end remodeling.  
Relative to nucleotide excision repair or base excision repair, where excision is typically 
followed by synthesis, then ligation (“cut, copy, and paste”; e.g. 45), this hierarchy of attempted 
enzymatic step is inverted. An inverted base excision repair analogy may extend to how NHEJ 
ensures continuity in attempted enzymatic steps. “Hand-off” to the next step in base excision 
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repair is thought to be aided by recognition of the prior step’s enzyme-product complex, rather 
than simply recognition of free product 45,46. In NHEJ, we’ve argued the first step is attempted 
formation of a productive, closed configuration by LIG4 (Fig. 2.7, step 1). We propose transition 
to the next step in this pathway involves recognition by end processing enzymes not of a 
productive enzyme-product complex (as in base excision repair), but of the unproductive, open-
configuration LIG4-substrate complex (Fig. 2.1, steps 2 and 3). Such a mechanism is enabled by 
the tethering of LIG4 to substrate even in its open configuration, through interactions between its 
C-terminal domain and a well-discussed DNA-protein “splint” (XRCC4, XLF, Ku, and DNA-
PKcs) 47-49. Additionally, both X family polymerases 50 and Artemis 51 directly interact with 
LIG4. An interesting possibility is that these interactions require LIG4 to be in its open 
configuration. A key role of the ligase in organizing end-processing is further supported by 
recent studies studying NHEJ with catalytically defective LIG4 52,53. Of note, the enzymes that 
engage ends in successive steps will also dictate discrete changes in how ends are configured, 
which in turn will allow for sampling of alternate alignments (Fig. 2.7).  
Channeling of substrate to different paths due to differing context (substrate, cell type) is 
efficient (Fig. 2.2d,e; 2.5b,c). This implies transitions between different steps of multiple step 
pathways occur without intervening dissociation of a given end-pair. All three alignment-
directed paths are also in total enriched when cellular incubation was limited to 15 minutes, 
relative to 5 hours (Fig. 2.4). Taken together, our results imply accurate NHEJ occurs within a 
sustained paired-end complex capable of, as needed, rapid and seamless sampling of all three 
methods for engaging ends and completion of accompanying catalytic steps (Fig. 2.7).  
A resolution requiring more steps does not necessarily require more time in the cell to 
accumulate. Rather, two-step resolutions can accumulate more rapidly than one step resolutions, 
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when the former resolution path is favored  (Fig. 2.4b, cf. Synthesis versus Direct). This is best 
explained if successive engagements of ends by different enzymes occurs within a stable 
complex, is reversible, and reaches equilibrium within 15 minutes (Fig. 2.7). Increasing terminal 
distortion may make the ligase closed-configuration less tenable, which then shifts the 
equilibrium to promote more frequent interaction of termini with end processing enzymes. This 
model explains how resolution steps can be easily adapted in graded fashion to account for 
different contexts; most obviously for differing substrate (as discussed above), but also differing 
availability of end processing enzymes in different cell types. For example, HCT 116 cells more 
readily employ synthesis as a compensating mechanism, relative to melanocytes  (Fig. 2.5b,c; 
p<0.0001, Table 2.1), possibly due to differences in availability of the X family polymerases 
implicated in the synthesis step.  
Heterogeneity and error is derived from a fourth class of products (Fig. 2.1a iv). These 
resolutions accumulate only slowly in the cell and though not guided by alignment of 
complementary sequence in the overhang, they include microhomology-mediated junctions (i.e. 
guided by complementary sequence in flanking double stranded DNA; Fig. 2.4c). We suggest 
these junctions form when processing is uncoupled from the paired end complex (Fig. 2.7, step 
4). Processing may have occurred prior to engagement of ends by the core NHEJ machinery, 
and/or resolutions may be mediated by another end joining pathway (Alt-NHEJ).  
The above suggested organization of attempted steps, as well as how well the type of 
enzymatic step is dictated by initial end structure, contrasts with currently favored models for 
NHEJ. We show the decision whether or how to process complex ends is not stochastically 
determined, nor is there a threshold of terminal distortion where resolution path discretely 
switches from direct ligation to processing-dependent resolutions. Resolution path is instead 
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adaptive. Direct ligation is attempted first, to take advantage of a unique effectiveness of the 
ligation step in NHEJ in bypassing subtle damage at DSB termini. However, we suggest the 
ligase can also act effectively as a damage sensor. When damage can’t be easily bypassed by 
direct ligation, it promotes coupling of failed ligation to an appropriate response, where 
processing enzymes perform the minimum steps necessary to turn a given aligned end-pair into a 
substrate that can now be ligated. 
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Figure 2.1: Design of substrates  
(a) Substrate TGCG3’ is shown; this and related substrates all possess symmetric head and tail 
end structures that can be aligned to allow for resolution by i) direct low-fidelity ligation of a 
terminal mispair, ii) gap fill-in synthesis and ligation, iii) excision of the terminal mispair, gap 
fill-in synthesis, and ligation (edit), or iv) other deletions. Nucleotides added during resolution 
are bolded. (b) Left panel; TGCG3’ overhang substrate (generates G/T mispair; S) was incubated 
with Ku, XLF, XRCC4-LIG4 complex, and with and without Pol λ (left panel) to generate 
concatemer ligation products (P). Right panel; junctions were characterized by amplification and 
mock digested or digested with restriction enzymes diagnostic for direct ligation (Dir.) or 
synthesis and ligation (Syn.) (Fig. 2.8a). (c) A substrate with AGCG3’ overhangs (generates G/A 
mispair) analyzed as in panel (b). 
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Figure 2.2: Cellular assay for NHEJ of systematically varied end structures  
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Figure 2.2: Cellular assay for NHEJ of systematically varied end structures  
(a) Description of cellular assay.  (b) Joining efficiencies for each substrate, comparing wild type 
HCT 116 cells to its LIG4 deficient variant (LIG4-/-). Error bars denote the standard deviation for 
12 (5’GATC, 5’GCGT) or 6 (all others) independent electroporations. (c) Substrates possessed 
end structure varied as shown. Product structures were defined as in Fig. 2.1a, and the proportion 
(%) of each determined by sequencing of junctions from wild type cells, averaged from two 
libraries, each library from a pool of 3 electroporations (see also methods). Error bars represent 
the range of results from the two libraries. (d), (e) The change in proportion of each resolution 
path due to differing terminal mispairs was calculated by subtracting mean proportions for each 
category of product, first (d)TGCG3’ (3’ G:T) from AGCG3’ (3’ G:A), then (e) 5’GCGT 
(5’G:T)  from 5’GCGA (5’ G:A).  
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Figure 2.3: Characterization of junctions with deletions  
(a) Deletions were categorized according to whether deleted sequence was entirely limited to the 
single stranded overhangs (ssDNA deletion), then further categorized as whether the junction 
equaled the “edit” product described in Fig 2.1a, iii, vs. all other ssDNA deletions. Similarly, 
junctions where deleted sequence extended into flanking double stranded DNA (dsDNA 
deletion) then classed as occurring at a flanking sequence identity (microhomology mediated) or 
not (other dsDNA) (b) Proportions of junctions with deletion (Fig. 2.1a, iii and iv) from Fig. 2.2c 
results were further categorized as in panel (a). Error bars represent the range of results from the 
two libraries. (c) The area of each slice is representative of the proportion of a different junction 
sequence with ssDNA deletion, as a fraction of the total sequences with ssDNA deletion (Fig. 
2.3a). The proportion of edits (Fig. 2.1a, iii) is distinguished from deletions not guided by 
overhang sequence complementarity.  
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Figure 2.4: Changes in resolution path over time in the cell 
(a), and (b) The change in proportion (%) of resolution path, comparing product recovered 5 h vs 
15 min in cells, for 5’GCGT (a)  and AGCG3’ (b). (c) The frequency of different junctions, 
distinguishing accurate (filled section), microhomology directed deletions (diagonal bars), and 
all other deletions (open sections) for 5’GCGT vs AGCG3’ substrates, after 15 min versus 5 h in 
cells. 
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Figure 2.5: NHEJ of systematically varied end structures in melanocytes  
(a) Selected substrates were introduced into melanocytes (NHM) and characterized as described 
in Fig. 2c, except results are from three independent libraries (9 electroporations). (b), (c) The 
change in proportion of each resolution path comparing NHM and HCT116 cells for substrates 
TGCG3’ (b) and 5’GCGT (c).  
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Figure 2.6: NHEJ of ends with a terminal 8 oxoguanine  
(a) Joining efficiencies for each substrate and cell line, all compared to joining of undamaged 
5’GATC in wild type cells.  Error bars represent the standard deviation from 6 independent 
electroporations. Joining in LIG4-deficient cells was significantly different for 5GOATC 
compared to the other two substrates (*, p<.05; ****, p<.0001; ; one way ANOVA comparing 
results of 6 independent electroporations for each group, with p values adjusted to account for 
multiple comparisons by the Bonferoni method). (b) The proportion of junctions joined by noted 
resolution paths in HCT 116 cells after 15 min in cells, averaged from two libraries, each library 
from a pool of 3 electroporations. Error bars note the range. (c), (d) The change in proportion of 
each resolution path comparing 5 h vs 15 min, for HCT 116 cells (c) and melanocytes (d). (e) 
Pathways for replacing GO with undamaged G. 
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Figure 2.7: Model for organization of enzymatic steps during NHEJ  
A model for the order of steps and the configurations of ends and enzymes during repair by 
Nonhomologous end joining. 
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Figure 2.8:  In vitro NHEJ assay   
(a) Shown is the scheme for using diagnostic restriction enzymes to distinguish Direct vs. 
synthesis dependent resolutions for the substrate employed in Fig. 2.1b (TGCG3’). For Fig. 2.1c 
(AGCG3’), direct joins are similarly sensitive to BstXI, while synthesis dependent resolutions 
are now sensitive to Nru I. (b) TGCG3’ overhang substrate (generates G/T mispair; S) was 
incubated with no protein or Ku, XLF, XRCC4-LIG4 complex, and with or without dNTPs and 
Pol λ to generate concatemer ligation products (P). The joining efficiency (relative to the 
maximal achieved for the experiment) for each individual reaction was calculated by qPCR and 
indicated below each lane. (c) 5’GATC (left) and TGCG3’ (right) overhang substrates were 
incubated with no protein or with Ku, XLF and ligase. The ligase was XRCC4-LIG4 complex or 
T4 DNA ligase, and reactions further supplemented with Pol λ as indicated. The relative joining 
efficiency for each reaction is indicated below each lane.  
 55 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.9: Validation of cellular assay for NHEJ 
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Figure 2.9: Validation of cellular assay for NHEJ 
(a) Substrates were HinfI digested, labeled, and resolved by denaturing polyacrylamide gel 
electrophoresis. AGCG3’ is a single nucleotide shorter than other substrates, due to a one 
nucleotide deletion located in substrate, but outside the junction amplicon. (b) qPCR standard  
curve, correlating mean threshold cycle (Ct) with number of amplicon molecules, determined by 
amplification of three independent serial dilutions (error bars are the standard deviation ) of a 
model amplicon into mock transfected cellular DNA. The solid line is a best fit of this 
correlation determined by linear regression (Prism, Graphpad).  Efficiency=-1+10(-1/slope). (c) 
Representation of sequencing library workflow. (d) A control amplicon with an embedded 
degenerate tetramer (cartoon) was amplified using the same number of input template molecules 
and processed the same way as experimental samples. The number of reads for each 
sequence/total reads (18883) is plotted for each of the 256 (44) sequences recovered.   
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 Figure 2.10: Supplementary characterization of cellular NHEJ 
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Figure 2.10: Supplementary characterization of cellular NHEJ 
(a) Time course of accumulation of joined products of the substrate AGCG3’ introduced in HCT 
116 cells, determined by qPCR and expressed relative to the average products detected after 1 
hour. Error bars represent the standard deviation from the mean determined from 6 independent 
electroporations. (b) Frequency of single nucleotide substitutions for joined products of the 
substrate AGCG3’ introduced in HCT 116 cells is shown for two sequence libraries for each 
position over a portion of the junction. Sites of cellular gap fill-in synthesis activity are bolded. 
For comparison purposes, the sample processing-derived mean substitution error and one 
standard deviation (determined using a control amplicon generated by ligation of 5’GATC in 
vitro by T4 ligase) are represented by solid and dashed lines, respectively.  (c) A schematic 
illustrates skipping of either the i) first nucleotide or the ii) second nucleotide by the polymerase. 
5’GCGT is shown here, but this mechanism is applicable for all partially complementary 
substrates studied. (d) Product structures were defined as in (b) and the frequency of nucleotide 
skipping was calculated as a proportion of total junctions for this class, as determined in Fig. 
2.2c. Error bars represent the range of results from the two libraries. 
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Figure 2.11: Fpg sensitivity of junctions containing 8-oxoguanine 
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Figure 2.11: Fpg sensitivity of junctions containing 8-oxoguanine 
(a) Joining efficiencies for two substrates and two cell lines, each compared to joining of 
undamaged 5’GATC in Ku70-/- cells complemented with WT Ku70.  Error bars represent the 
standard deviation from 6 independent electroporations. Joining in Ku70-deficient cells was 
significantly different for 5’GOATC compared to the 5’GATC    (****, p<.0001). (b,c) Fpg 
resistance, estimated by qPCR, comparing relative amplification of template treated with Fpg 
versus mock untreated, is determined for products of joining with the noted substrates, generated 
either in vitro (T4) or in the noted cell types. Error bars are the standard deviation from results of 
6 independent electroporations (cells) or 3 independent treatments of T4 ligated substrate. 
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Hypotheses: is A>B?* Odds Ratio 
95% Wald  
Confidence 
Interval 
A B   
HCT116, 5’GATC, Direct HCT116, 5’GCGT, Direct 2.807 2.263 – 3.482 
HCT116, 5’GCGT, Direct HCT116, 5’GCGA, Direct 58.824 52.632 – 66.667 
HCT116, 5’GCGA, 
Synthesis 
HCT116, 5’GCGT, 
Synthesis 53.085 36.694 – 76.799 
HCT116, TGCG3’, Direct HCT116, CTAG3’, Direct 19.021 16.807 – 21.528 
HCT116, TGCG3’, Direct HCT116, AGCG3’, Direct 5.988 5.000 – 7.194 
HCT116, AGCG3’, 
Synthesis 
HCT116, TGCG3’, 
Synthesis 2.795 2.589 – 3.016 
HCT116, 5’GCGA, Direct HCT116, AGCG3’, Direct 1.560 1.280 – 1.905 
HCT116, 5’GCGT, Direct HCT116, TGCG3’, Direct 15.152 13.699 – 16.667 
NHM, 5’GCGT, Direct NHM, 5’GCGA, Direct 34.483 21.277 – 55.556 
NHM, 5’GCGT, Direct NHM, TGCG3’, Direct 25.000 19.608 – 31.250 
HCT116, 5’GCGA, 
Synthesis NHM, 5’GCGA, Synthesis 4.864 2.822 – 8.382 
HCT116, TGCG3’, Synthesis NHM, TGCG3’, Synthesis 1.779 1.434 – 2.207 
 
Table 2.1: Tests of hypotheses  
*Proportions of interest were compared as described in methods, and the null hypothesis was 
rejected for all hypotheses tested (p<.0001).  Point estimates and 95% Wald confidence intervals 
for each A:B odds ratio are listed in adjacent columns. 
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CHAPTER 3: ESSENTIAL ROLE FOR POLYMERASE SPECIALIZATION IN 
CELLULAR NONHOMOLOGOUS END JOINING 
 
3.1 Introduction 
 
Chromosome breaks are most often repaired by Nonhomologous end joining (NHEJ) in 
mammals. This pathway is thus essential for assembly of the antigen receptor genes (Ig, TcR) 
required for adaptive immunity, normal cellular replicative capacity, nervous system 
development1, and shapes the effectiveness and safety of break-inducing cancer therapies 
(ionizing radiation, certain chemotherapeutic agents)2. Repair is accomplished by directly 
ligating broken ends together. This makes NHEJ unique amongst the major DNA repair 
pathways, as an unbroken template cannot easily be used to guide replacement of lost or 
damaged nucleotides by DNA polymerases. Polymerase-dependent synthesis might thus be 
expected to play a lesser role in NHEJ, relative to the other DNA transactions (excision, ligation) 
required for DNA repair.  
Nevertheless, at least three different members of the mammalian X family of DNA 
polymerases can be specifically implicated in NHEJ; Pol λ, Pol µ, and terminal deoxynucleotidyl 
transferase (TdT)3. All three of these polymerases contain N-terminal BRCT (breast cancer 
carboxy terminal associated) domains, which confers upon the polymerases the ability to form 
stable complexes with the core NHEJ factors Ku, XRCC4, and ligase IV. All three polymerases 
are also active in synthesis during NHEJ in vitro, but there is an abundance of evidence for 
structural elements unique to each polymerase that account for striking differences in these in 
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vitro activities [e.g4-8]. Most clearly, the general character of synthesis activities have a gradient 
of decreasing dependence on an intact template strand, Pol λ> Pol µ > TdT9,10, that in part can be 
attributed to differences in a variable insert in the palm subdomain (Loop1)9,11,12. However, 
evidence that these different in vitro activities effects the biological role of these polymerases is 
definitive only for TdT, which adds template independent nucleotides (N additions) to broken 
intermediates during V(D)J recombination. Accordingly, TdT is expressed only in cells active in 
V(D)J recombination13.  
By comparison, both Pol µ and Pol λ are widely expressed14,15, and it has been difficult to 
clearly link phenotypes of deficiency in these polymerases to an important role for them in 
NHEJ. For example resistance to ionizing radiation, a hallmark of proficiency in NHEJ, is not 
affected by deficiency in Pol λ16,17, while the effects of deficiency in Pol µ on resistance to 
ionizing radiation depends partly on cell type16,18,19.  Effects of these polymerases on the fidelity 
of NHEJ have also been observed [e.g.9,10,16,20-23], though interpretations vary as to whether 
differences in catalytic activities are important (i.e. they are redundant), or even if their catalytic 
activities are relevant at all. Much of the uncertainty can be attributed to changes in relative 
expression level comparing different cell types, and especially difficulties in unambiguously 
defining the substrates upon which the polymerases acted in these cellular experiments.  
We therefore systematically varied both substrate and polymerase in a cellular setting. We 
identify contexts where only Pol µ or Pol λ, amongst all of the DNA polymerases expressed in 
mouse embryo fibroblasts, are active – their cognate substrates – and clarify the mechanistic 
basis for their specific activities. We show how their differing activities promotes accurate 
repair, and that the ability of either to perform synthesis in this challenging context is 
surprisingly essential.  
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3.2 Methods 
Cell lines 
 
Polm-/- mice were generated as previously described31, Pol l-/- mice were generated by 
disruption of exon 5, and these two mice crossed to generate Polm-/-Poll-/- double knockout 
mice. Murine embryonic fibroblasts (MEF) were generated from E14.5 day embryos from WT 
(C57Bl/6) as well as Poll-/-, Polm-/-, and Poll-/-Polm-/- mice, and immortalized by infection with a 
retrovirus that expresses SV-40 large T antigen (Addgene, #1779). Genotypes were confirmed 
using PCR and western-blot analysis. Cells overexpressing either myc-tagged wild type or 
catalytically inactive polymerase variants were generated by infecting the Polm-/-/Poll-/- cells 
with retrovirus derived from pBabe-puro constructs containing the appropriate murine cDNAs, 
and comparable levels of expression verified by western blot. Ku70-/-p53-/- cells were obtained 
from Dr. P. Hasty (UTHSCSA), and then complemented by expression of the mouse Ku70 
cDNA (+Ku70) or the pBabe-puro empty vector (vec). All cell lines were maintained in 
Dulbecco's Modified Eagle's medium supplemented with 10% FBS (Sigma), 5 mM N-Acetly-L-
cysteine (Sigma), 2 mM L-Glutamine (Gibco), 1X penicillin-streptomycin, and 2 µg/ml 
puromycin (if necessary), at 37°C and 5% CO2. 
Generation of DSB repair substrates 
 
Substrates were prepared by PCR amplification of a common 285 base pair DNA 
segment with primer pairs containing embedded restriction enzyme digest sites chosen to 
generate the desired end structures. The primer pairs and restriction enzymes used for each 
substrate are listed in Table 3.1. Substrates were purified using the QIAquick PCR purification 
kit (Qiagen), and complete digestion of each substrate was validated by native gel 
electrophoresis. Two substrates were selected for further validation that this procedure is 
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sufficient to generate the intended end structures at nucleotide-level resolution. These substrates 
were sequentially treated with HinfI, shrimp alkaline phosphatase, and T4-kinase in the presence 
γ-32P-ATP, and analyzed by denaturing gel electrophoresis (Fig. 3.13a). 
Extrachromosomal DSB repair assay 
 
Extrachromosomal DNA substrates (20 ng) and pMAX-GFP plasmid (600 ng) were 
introduced into the MEF cell lines (2 x 105 cells per transfection) by electroporation using a 1350 
V, 30 ms pulse in a 10 µL chamber (Neon, Invitrogen). After electroporation cells were 
incubated in fresh media without antibiotics for 1 hour at 37°C to allow time for the cells to carry 
out end joining. Cells were then washed with phosphate buffered saline and then the total cellular 
DNA was harvested using a QIAamp DNA mini kit as per the manufactures instructions 
(Qiagen). Each electroporation was performed in triplicate, and repeated in triplicate on a second 
day. The complementation of cells with purified proteins was performed as above with the 
addition of 1-1,000 ng of protein to the substrate transfection solution immediately prior to 
electroporation. The proteins used in this study were expressed an purified as described 
previously4,7. 
 Recovery of joined products was quantified by real-time PCR (qPCR) using an ABI 
7900HT or QuantStudio 6 System (Applied Biosystems), primers that amplify head-to-tail 
junctions (5’ – CTTACGTTTGATTTCCCTGACTATACAG & 5’ – 
GCAGGGTAGCCAGTCTGAGATG), and SYBR green detection. This assay has previously 
been validated as efficient, reproducible, and linear over the range relevant to these experiments2. 
The number of junctions recovered from cells was determined by comparison of the threshold 
cycles (CT) to a standard curve run in parallel, generated by serial dilution of a model amplicon 
into DNA harvested from mock transfected DNA.  
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Joining efficiency (Jeff) was determined by comparing the number of junctions recovered 
from cells deficient in the polymerases or Ku, to the number of junctions recovered from a 
matched wild type cell line electroporated in parallel (wild type Jeff≡1). The proportion of 
specific junction sequences in each sample (P) was then typically determined (Figs. 3.1b, 3.2a, 
3.2b, and Figs. 3.3-3.5) by amplification and sequencing on the Illumina Miseq platform (see 
below). In selected cases (Figs. 3.1c, 3.2c, and Figs. 3.8-3.10) junctions were characterized by 
diagnostic restriction enzyme digests on repair products that were amplified using Cy-5 labeled 
versions of the primers described above. The restriction enzymes used for each substrate were as 
follows: NsiI for products of G3’, AatII for products of GCAG3’, or AfeI for products of 
GCG3’. Digestion products were resolved on a 5% native polyacrylamide gel and visualized 
using a Typhoon Imager (GE Healthcare). Quantification of relative band intensities was carried 
out using ImageJ software. 
The efficiency of recovery for each junction was then defined as Jeff*P. Whether differences 
in means of recovery efficiencies were significant was assessed by one-way ANOVA test, with 
the p-values adjusted to account for multiple comparisons by the Bonferroni method. 
Next generation sequencing  
 
Sequencing was performed in two separate runs. Template DNA for each sequencing library 
was prepared by pooling the three independent electroporations performed on a single day. 
Amplification of 5 x 105 input molecules (calculated from qPCR) was performed using Phusion 
DNA polymerase (NEB) and variants of qPCR primers possessing six-nucleotide barcode 
sequences appended to their 5’-ends for 21 cycles. Amplified DNA (15.5 ng/library) were pooled 
into groups of 8-12 libraries, 5’phosphorylated, and treated with Klenow exo- to add dA to the 
3’termini (NEB). The ends were then ligated to adapters for paired-end sequencing (Illumina). 
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Agarose gel purification was used to remove free adapter. A final enrichment amplification of 10 
cycles was performed, and products again purified (Agencourt Ampure XP, Beckman Coulter).  
Either 180 ng (Sequencing run 1) or 70 ng (Sequencing run 2) of the purified DNA from each 
group of libraries were then combined. These libraries were submitted for a 2 x 80 bp (run 1) or 
2 x 250 bp (run 2) sequencing run (MiSeq, Illumina). A PhiX174 DNA “spike” was included in 
each run. We additionally validated that sample diversity was maintained after amplification and 
sequencing by amplifying and sequencing a control template with an embedded degenerated 
tetramer, using the same input number of molecules as we used for experimental samples (5 x 
105; Fig. 3.13b).  
Reads of PhiX174 DNA were removed, adapter sequences stripped, read-pairs merged, and 
libraries de-indexed using Genomics workbench v7.5.1 (CLC-Bio). Sequences that were 
improperly de-indexed were identified by exact match to common sequences in other libraries 
and removed. Substitution error due to sample processing (1.2 x 10-3) was assessed by 
determining the average frequency of substitution at each position using a control library 
generated from the in vitro ligation of a 5’GATC substrate with T4-ligase. The single nucleotide 
substitution rate for sequences from experimental samples was not significantly greater than the 
control, except as noted in Figure 3.13c, thus analysis of experimental samples was restricted to 
counting exact matches to a list of uniquely identifiable sequences generated from all 
combinations of sequential terminal deletions. We also included in our analysis “N-additions”, 
defined as those junctions with sequence of any length or composition inserted between left and 
right ends. To compensate for reduced counts of exact matches due to processing-dependent 
sequence substitutions, we applied the formula y=x(1-(a*n)) where y is the corrected count, x is 
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the observed count of exact matches, a=1.2 x 10-3 (average substitution frequency of control 
library), and n is the length of the sequence. 
Cytotoxicity studies 
 
Experiments where cells were treated with ionizing radiation were carried out by seeding 
100-100,000 cells per 10 cm dish in fresh media lacking antibiotic 4 hours prior to treatment 
with varying doses of radiation using a RS 2000 biological irradiator (Rad Source Technologies). 
Colonies formed after 10 days post-treatment were stained using a crystal violet (0.5% w/v) 
solution. Experiments where cells were treated with methyl methanesulfonate (Sigma) and 
paraquat dicholoride (Ultra Scientific) were carried out similarly, but the cells were dosed for 4 
or 18 hours, respectively, prior to seeding. N-Acetyl-L-cysteine was omitted from the media for 
cells treated with paraquat dichloride. Plates containing a minimum of 50 colonies were counted 
by hand, and at least three plates were counted for each dose. 
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3.3 Results 
Pol µ and Pol λ are preferentially active on different substrates 
 
Substrates were introduced into C57Bl/6 mouse embryo fibroblasts (MEFs) that were wild 
type, deficient in Pol µ (Polm-/-), Pol λ (Poll-/-) or both. Conditions were optimized to reflect 
joining by classically defined NHEJ, as is evident from parallel experiments performed in mouse 
dermal fibroblasts lines with and without a factor essential for NHEJ (Ku70; Figs. 3.1-3.5). Head 
to tail joined products were characterized by qPCR to assess overall product recovery, and then 
sequenced to assess differences in product structures (Fig. 3.1a). We considered first only those 
products consistent with activity of a polymerase and ligase alone (Figs. 3.1-3.4) to more clearly 
evaluate polymerase specificity, but then also address the significance of polymerase activity 
after nucleolytic remodeling of the original substrate’s end structure (Fig. 3.5). 
Synthesis across a broken DNA backbone poses unique problems for DNA polymerases. The 
most extreme example of this occurs when ends with 3’ non-complementary overhangs pair, as 
complementary sequence can’t help align the primer with template. We therefore introduced 
such a substrate - a DNA fragment with a single 3’ overhanging G at both head and tail ends 
(G3’) - into the MEF panel described above. Head-to-tail junctions formed after incorporation of 
a single C, followed by end-ligation (+C products), accounted for 26% of those recovered from 
wide type MEFs, while this product was recovered 83 fold less frequently in Pol µ deficient cells 
(Fig. 3.1b). Similar results were also observed using an independently generated panel of MEF 
lines (Fig. 3.8). Incorporation of one or more nucleotides other than C (+N) was rare; such 
products accounted for only 0.5% of those recovered from wild type MEFs, and their recovery 
was equally affected by loss of Pol µ and Pol λ. 
We additionally complemented Polm-/-Poll-/- MEFs with increasing amounts of Pol µ, 
resulting in corresponding increases in recovery of the +C junction up to more than double that 
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observed in wild type MEFs (63% c.f. 26%; Fig. 3.1c). Participation of Pol µ during NHEJ in 
this cell type is thus limited by sub-saturating expression. Nevertheless, on this class of substrate 
(noncomplementary 3’ overhangs; Fig. 3.1 and Fig. 3.3a), even very low levels of Pol µ accounts 
for far more activity than the other polymerases expressed in MEFs. 
We considered two possible ways the lack of sequence complementarity at ends restricts 
activity to Pol µ; it's the only polymerase active when aligned ends lack complementary 
sequence to assist end-bridging, or it's the only polymerase active in such a context, but when the 
primer terminus is additionally single stranded (unpaired). To distinguish between these 
possibilities we generated a substrate with one blunt end and one 3’ G overhang (Blunt/G3’); 
synthesis must now initiate from a blunt end (double-stranded primer), but there is still no 
complementary sequence to promote end-bridging and primer/template alignment. Surprisingly, 
the contribution of the two polymerases to synthesis during NHEJ was inverted for this new 
variant substrate; recovery of the +C junction now relied primarily on Pol λ (Fig. 3.2a), even 
though this new substrate differed from that described in in Figure 3.1 by only a single 
nucleotide (Fig. 3.1b c.f. Fig. 3.2a).  
A similar reduction in junction recovery in Poll-/- cells is also apparent when using a 
substrate with partly complementary 3’ overhangs (GCG3’; Fig. 3.2b). In this context, there is 
again complementary sequence opposite the primer terminus, but only after alignment of a pair 
of ends. Additionally, on this substrate there is little synthesis associated with NHEJ in cells 
deficient in both Pol µ and Pol λ, thus other polymerases expressed in MEFs are much less active 
on GCG3’ than even Pol µ. Introduction of Pol λ into Polm-/-Poll-/- MEFs was also sufficient to 
recover activity on this substrate, but in contrast to Pol µ with G3’ (Fig. 3.1c), it was not possible 
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to significantly exceed the levels of Pol λ-dependent synthesis observed in wild type MEFs by 
addition of increasing amounts of Pol λ (Fig. 3.2c).   
When ends with 5’ overhangs align, gap-filling synthesis does not have to transit a strand 
break, and this less-challenging reaction has been shown to be largely independent of polymerase 
specialization in S. cerevisiae10. Consistent with this result, synthesis is 2.7-fold more efficient 
when comparing analogous 5’ vs. 3’ overhang substrates (Fig. 3.9 c.f. Fig. 3.2b), and at least 
when the gap is a single nucleotide there was no effect of deficiency in Pol λ or Pol µ (see also 
Fig. 3.3c).  
Specialized polymerases are thus required during NHEJ in any context where synthesis must 
transit a strand break; i.e. aligned ends where one or both ends have a 3’ overhang. Importantly, 
the context of the 3’ terminus then defines which of these two polymerases is most active. Pol µ 
alone can efficiently initiate synthesis during NHEJ from an unpaired 3’ terminus, while this 
polymerase is less active than Pol λ when there is complementary sequence opposite the 3’ 
terminus (Fig. 3.2d). 
Pol µ and Pol λ use different mechanisms to locate templating base  
 
These polymerases are thus essential for activity when the juxtaposition of primer and 
template must rely on interactions between these DNA molecules and the higher-order protein 
complex (i.e. NHEJ core factors and the polymerase) that mediates end-alignment. This raises 
questions as to how Pol µ and Pol λ locate the templating base, and whether they use the same 
mechanism for this. We addressed this issue using DNA ends that, in contrast to those described 
above, are expected to align such that they require synthesis of more than a single nucleotide 
before ligation can occur. 
 77 
We addressed this question first with non-complementary overhangs. Synthesis and ligation 
of a substrate with 2 nucleotide noncomplementary overhangs (TG3’) relied on Pol µ (Fig. 3.3a), 
similar to results with the comparable single nucleotide overhang substrate (G3’, Fig. 3.1a). 
However, the majority of these products involved synthesis of only a single A, the nucleotide 
complementary to the template base immediately adjacent to the site of ligation. By comparison, 
junctions with addition of nucleotides complementary to both overhang template positions 
(+CA) were 20-fold less frequent than +A, and comparable in frequency to junctions with 
repeated addition of A (+AA)  (Fig. 3.3a). Pol µ thus efficiently “skips ahead” to find template 
during synthesis of this substrate.   
We next addressed synthesis of longer gaps when the ends are partly complementary 
(GACG3’); again, this is comparable to a substrate described above (GCG3), except the gap after 
alignment is now 2 nucleotides instead of 1. Strikingly, we were readily able to recover products 
where both nucleotides were added  (+TC) for this substrate – in contrast to the 2 nucleotide non-
complementary overhang substrate – but this product is dependent on Pol λ (Fig. 3.3b). Similar 
results were also observed using an independently generated panel of MEF lines (Fig. 3.10). 
However, a less frequent product of skip-ahead synthesis (+C) was also observed, and similar to 
the non-complementary overhang substrate, this skip-ahead product required Pol µ (Fig. 3.3b). In 
the absence of both Pol µ and Pol λ junctions were reduced 3,000-fold. Thus, in sum, Pol λ is 
uniquely effective on this substrate and synthesizes both nucleotides of the 2 nucleotide gap and 
while Pol µ is the only significant alternative, it is over 10-fold less efficient and when active, 
skips ahead (Fig. 3.3b).  
As noted above, synthesis at ends with partly complementary 5’ overhangs has no specific 
requirement for either Pol µ or Pol λ, at least when end alignment generates a 1 nucleotide gap. 
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However, the unique effectiveness of Pol λ on 2 nucleotide gaps in the context of 3’ overhangs 
led us to re-address this question. Consistent with this idea, we show Pol λ is uniquely effective 
in synthesizing both nucleotides of a 2-nucleotide gap even on 5’ overhang substrates (+TT, Fig. 
3.3c). Notably, a skip-ahead product (+T) is again observed for this substrate, and depleted in Pol 
µ deficient cells. 
We conclude the two polymerases employ different cues for locating the templating 
nucleotide. Pol λ locates template nucleotides in normal sequence, progressing from 3’ to 5’ 
across any gaps present after end alignment. Pol µ instead identifies template primarily through a 
“spacing” rule, where it uses as template only the nucleotide adjacent to the site of ligation.  
Structural elements essential for polymerase specialization in cellular NHEJ 
 
We next addressed structural elements that could help distinguish the activities of Pol µ and 
Pol λ. When considering Pol µ, others and we have emphasized an extended loop insert (Loop1) 
in its palm subdomain9,11,12. Deletion of this loop (Pol µΔloop1), or substitution of a residue 
thought to help limit its mobility (Pol µF385A), specifically reduce activity on non-complementary 
ends (its cognate substrate) in vitro7. To determine if the requirement for this element is 
maintained during cellular NHEJ, we introduced the substrate with non-complementary 3’ 
overhangs (G3’) into Polm-/-Poll-/- MEFs, and then complemented these cells with various Pol µ 
constructs. As expected, introduction of wild type Pol µ was essential for recovery of products of 
template-dependent synthesis and ligation (+C product); by comparison, Pol µF385A was 1/3rd as 
effective as the wild type construct, and Pol µΔloop1 over 10-fold less effective (Fig. 3.4a left 
side).  
Activities for all three constructs (wild type, Pol µF385A, and Pol µ Δloop1) were nevertheless 
indistinguishable on a substrate with complementary sequence opposite the primer (Fig. 3.4a 
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right side); deleting or disabling the loop1 element thus impairs Pol µ activity on its cognate 
substrate, but doesn't make it generally unable to perform synthesis on other substrates. Deletion 
or mutation of the loop also doesn’t alter how the polymerase identifies template, as all three Pol 
µ constructs remain unable to fill in both nucleotides (+TC; Fig. 3.4b) when end align generates 
a 2 nucleotide gap. Instead, all three Pol µ constructs still skip ahead; indeed, when loop1 is 
deleted, the most frequent product involves repeated use of this template position (+CC product, 
Fig. 3.4b). The loop is thus an essential component of Pol µ specialization – it is required for 
activity on its cognate substrate – but deletion of the loop neither enables the polymerase on 
preferred substrates for Pol λ, nor reduces the tendency of this polymerase to skip-ahead on 
longer gaps.  
Prior structural studies also suggest Pol λ possesses an element that makes it uniquely suited 
for it’s cognate substrate4. When ends align to generate a 2 nucleotide gap, Pol λ can “scrunch” 
the next-to-be copied template nucleotide, by burying it in a pocket generated by amino acids 
L277, H112, and R514. We addressed whether this pocket was important for activity on 2 
nucleotide gaps in cells by complementing Polm-/-Poll-/- cells with wild type Pol λ, as well as a 
Pol λ construct where these residues were substituted with alanine (Pol λ 3A).  This mutant 
construct had generally reduced activity, but the degree of reduction was much greater on the 
substrate with ends that align to generate a 2 nucleotide gap vs. a 1 nucleotide gap, in accord 
with a central role for this pocket in promoting synthesis on the longer gap (Fig. 3.4c).  
Polymerase specialization is essential for NHEJ 
 
We identified cognate substrates for each polymerase above by excluding products where it 
was clear the initial substrate’s end structure had been remodeled by nuclease activity (Figs. 3.1-
3.4). Here we address the impact of polymerase deficiency on NHEJ overall, by extending 
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analysis to all products. We represent in Figure 3.5 the relative recoveries of different products 
or product classes as different sectors of a pie first for wild type cells. For polymerase deficient 
cells the areas of each pie sector are adjusted to reflect the recovery efficiencies, relative to wild 
type cells, for corresponding products (or product classes). The angle of rotation for each sector 
is kept constant to emphasize how the effects of polymerase deficiency vary for different 
products, and the overall joining efficiency (i.e. summing together all products; Jeff) for each line, 
relative to matched wild type control, is listed. 
As previously emphasized (Fig. 3.1) G3’ originates as a cognate substrate for Pol µ; this is 
apparent by the 83-fold reduction in the area of the dark blue sector in Polm-/- cells, relative to 
the wild type control line (Figs. 3.5ai, 3.5b c.f. top left and top right quadrants).  However, there 
is an inverted dependency on polymerase for a second major product of this substrate (Fig. 
3.5aii, light blue); recovery of this product is reduced 23-fold in cells deficient in Pol λ and not 
significantly impacted by deficiency in Pol µ (Fig. 3.5b). Taking into account the product 
structure and previous analysis (Fig. 3.2a) we infer that the initial substrate, a cognate substrate 
for Pol µ, was remodeled by nuclease activity into a cognate substrate for Pol λ (Fig. 3.5aii). 
Using a substrate initially “cognate” for Pol λ (GACG3’) we again observed a pattern of 
alternating dependency on one or the other polymerase, though there are many more 
permutations of products with partial overhang loss (sectors with different blue shades, Fig. 3.5d-
f, Fig. 3.11). Remodeling of overhangs by nuclease activity thus adds to the flexibility of end 
processing during NHEJ. However, the specificity of each polymerase is retained after overhang 
remodeling, and their presence remains integral to efficient joining of the remodeled end 
structures. 
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The remaining products – those where both overhangs are lost, including deletions that 
extend dsDNA flanking sequence – are also reduced in polymerase deficient cells, but for these 
products the degree of reduction is similar regardless which polymerase is missing. This can be 
explained if nuclease activity generates heterogeneous intermediates, where some are cognate 
substrates for Pol µ and others are cognate substrates for Pol λ; however, as diagrammed for a 
product where both overhangs are lost (Fig. 3.5biii), the same product can then be generated by 
activity of either polymerase on their different cognate substrates. Moreover, for these product 
classes it is also possible to generate intermediates that can be directly ligated, independent of 
polymerase activity (i.e. when by chance, nuclease activity precisely removes both overhangs). 
This is especially relevant for microhomology-directed deletions (red segment), where the 
intermediates potentially have complementary overhanging sequence (“sticky ends”). These 
products consequently account for a much larger fraction of the residual products recovered from 
polymerase deficient cells. 
We thus observe very striking differences in product spectra when comparing cells deficient 
in a single polymerase. At the same time, nuclease activity often converts end structures that are 
a cognate substrate for one polymerase into the cognate substrate for the other, so there is 
typically only a modest impact (<3-fold) on overall joining efficiency (Jeff, Fig. 3.5) in these 
cells. In contrast, the efficiency of joining is reduced  ~20-fold in cells deficient in both. Residual 
products are also almost entirely comprised of those with both overhangs lost and 
microhomology-directed deletions.  This impact of deficiency in both polymerases on overall 
joining efficiencies, as well as the spectrum of products generated, is similar to that observed 
after complete loss of NHEJ (i.e. due to deficiency in Ku, Figs. 3.5c, 3.5f).  
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These results are readily reconciled with an assay of gross phenotype. Both of the cell lines 
deficient in a single polymerase were at best mildly sensitive to a DSB-inducing agent, ionizing 
radiation (IR), while cells deficient in both polymerases were much more clearly IR sensitive 
(Fig. 3.6a). Doubly deficient cells were not sensitive to sources of DNA damage that do not 
directly introduce DSBs (methyl-methane sulfonate, Fig. 3.12b, and paraquat, Fig. 3.12c), and a 
similarly specific sensitivity to ionizing radiation was observed using an independently generated 
panel of MEF lines (Fig. 3.12a). Moreover, overexpression of either wild type Pol µ or Pol λ 
alone was sufficient to complement the radiosensitivity observed in cells deficient in both (Fig. 
3.6b). We were also able to confirm catalytic activities were essential for this complementation, 
using catalytically defective variants of these polymerases. Indeed, expression of either 
catalytically inactive polymerase resulted in a severe hypersensitivy to IR, relative to even the 
parental doubly deficient line. 
3.4 Discussion 
Polymerase specialization 
 
17 different DNA polymerases are widely expressed in mammals, arguing disparate needs 
for DNA synthesis has driven a high degree of specialization. We show here how two of these 17 
polymerases are specifically designed to direct synthesis across a broken DNA backbone - 
synthesis in a context that is unique to, and we show here is essential for, efficient repair of 
double strand breaks by Nonhomologous end joining.  
Pol µ alone had significant activity on all of the substrates tested. This flexibility was largely 
attributable to its ability to prime synthesis from a single-stranded terminus (Fig. 3.1), but a 
consequence of this characteristic activity is that it is not possible to use canonical means for 
identifying template. Accordingly, accompanying work (Moon et al, in preparation) and we 
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show this polymerase typically chooses its template during cellular NHEJ by following a “1 
nucleotide gap rule”, where the unpaired base adjacent to the downstream 5’ phosphate is used as 
template, even when there are available template sites further upstream of this position - the 
polymerase skips-ahead (Fig. 3.3a-c, Fig. 3.13c, and Fig. 3.7a). While deletion or mutation of the 
loop1 motif of Pol µ impairs its ability to prime synthesis from single-stranded termini, the 
mutant polymerases still locate template by skipping-ahead (Fig. 3.4b), indicating these two 
facets of Pol µ specialization can surprisingly be uncoupled from each other.  
Like Pol µ, Pol λ is able to synthesize over broken template, but Pol λ accounts for the 
majority of synthesis activity when there is complementary sequence opposite the primer 
(dsDNA primer; Fig. 3.2). Pol λ also solves the problem of locating template in such contexts 
differently than does Pol µ; when ends align to generate a 2 nucleotide gap, only Pol λ has 
significant ability to incorporate both nucleotides (Fig. 3.3). We show Pol λ is uniquely 
proficient on the longer gap is because it employs a variation of the 1 nucleotide gap rule; like 
Pol µ, it maintains the arrangement of strand break termini as if it were a single nucleotide gap, 
but now does so by scrunching the downstream template base within a pocket unique to this 
enzyme4 (Fig. 3.4c; Fig. 3.7a).  
Indeed, for ternary structures of either polymerase on a 1 nucleotide gap6,24, Pol λ scrunched 
on a 2 nucleotide gap4, and Pol µ skipping-ahead on a 2 nucleotide gap (Moon et al. in 
preparation), both the distances between the two strand break termini as well as the angles of 
upstream and downstream strands are nearly the same (“the 1 nucleotide gap rule”; Fig. 3.7a, and 
Moon et al. in preparation). As noted above, our work argues these 4 structures are sufficient to 
model the majority of end-alignment configurations expected to be relevant to the activity of 
specialized polymerases during NHEJ. We suggest the single spatial arrangement of strand-break 
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termini observed in these structures is driven by a need to incorporate polymerase activity within 
the NHEJ paired-end complex (including Ku, XRCC4, ligase IV, XLF, and PAXX), which 
assumes the burden of “pre-assembling” the substrates for these polymerases (Fig. 3.7b). 
However, the paired-end complex cannot reasonably sample enough different end-alignment 
configurations to keep pace with substrate diversity. Accordingly, the two polymerases elegantly 
address this problem by adjusting only the template strand, and only immediately upstream (Pol 
µ)(Moon et al. in preparation) or downstream (Pol λ)4 of the nascent base pair binding site (Fig. 
3.7a). 
Significance of polymerase specialization to NHEJ 
 
The ligation step during NHEJ is much less tolerant of mispairs and other distortions when 
these are 3’ of strand breaks, relative to 5’ of strand breaks 2. As a consequence, synthesis that 
initiates from 3’ overhangs or blunt ends - and which then is sufficient to generate paired termini 
3’ of strand breaks - is especially significant to this pathway. Pol µ and Pol λ alone amongst 
mammalian polymerases address this problem, but employ different solutions.   
Pol µ allows retention of activity on a wider range of substrates, relative to Pol λ; it can make 
any end with a 3’ overhang, regardless of sequence (and possibly associated damage as well), 
somewhat of a “universal donor” for the ligation step. This might explain why phenotypes of Pol 
µ deficiency, including immunodeficiency, impaired hematopoiesis, and cellular radiosensitivity, 
can be more severe than phenotypes of Pol λ deficiency16,19,25. Pol λ is nevertheless more active 
than Pol µ for some substrates, and on a subset of these – 2nt gaps – Pol λ allows for retention of 
an extra nucleotide in the product, and thus is more accurate.   
The increased accuracy of Pol λ in this context is most clearly significant to NHEJ as a 
means to further enable ligation. Pol µ activity on the same substrates indeed generates a paired 
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3’ terminus (“a universal donor”), but this is not an ideal solution, as the one or more mispairs 
that are upstream of the site of ligation still interferes with the ligation step. There may be 
additional negative consequences of employing only Pol µ for repair; for example it is prone to 
generating mononucleotide repeats25 26 (Fig. 3.3a, Fig. 3.13c), and indeed Pol m-/- mice have 
been characterized as healthier than their matched wild type counterparts in some respects27. As 
a means to possibly limit these negative consequences the levels of Pol µ, but not Pol λ, 
expressed in MEFs is sub-saturating with respect to its ability to contribute to NHEJ (Fig. 3.1c 
cf. Fig. 3.2c), and high levels of Pol µ expression are restricted to a very short window in B cell 
development16. We suggest that there is a hierarchy of polymerase usage, where the more 
accurate Pol λ is typically given priority in most cell types – this is similar to the hierarchy of 
polymerase usage described in the bypass of UV photoproducts.  
Together these two polymerases make up a comprehensive toolbox that is essential for repair 
of diverse end structures by NHEJ. The results described in Figure 3.5d provide a particularly 
striking example of this; we observed significant amounts of 8 different permutations of product 
that included overhang loss (blue sectors), and one or the other polymerase was typically 
essential for each one. However, the ability of this pathway to also employ nuclease(s) to process 
ends means the cognate substrate for one polymerase can frequently be altered to generate a 
cognate substrate for the other (Fig. 3.7b). Therefore, loss of one or the other polymerase alone 
has a mild impact on overall NHEJ efficiency, while the impact of deficiency in both 
polymerases is severe, with levels indistinguishable from those observed in Ku deficient cells for 
some substrates (Fig. 3.5). Deficiencies in these specialized polymerases also have a synergistic 
impact on overall NHEJ efficiency using a gross measure of chromosomal double strand break 
repair (sensitivity to ionizing radiation; Fig. 3.6). 
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We show here that Pol µ and Pol λ are uniquely effective when synthesis must transit a strand 
break, and thereby play a key role in classically defined Nonhomologous end joining. Strikingly, 
one other eukaryotic polymerase has a related activity - Pol θ also directs synthesis across double 
strand break ends, though it needs a short patch of terminal complementary sequence, or 
microhomology, to initiate synthesis – and it is essential for an alternate Nonhomologous end-
joining pathway28-30. More complex and longer-lived organisms are expected to need more 
flexible and efficient versions of end joining; it is clear that the employment of specialized 
polymerases is an integral part of how this has been achieved.  
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Figure 3.1: Synthesis primed from ends with an unpaired 3’ terminus 
(a) Description of the extrachromosomal DSB repair assay. (b) The G3’ substrate (described in 
cartoon) was introduced into the noted fibroblast cell lines. For each cell line, the efficiency of 
recovery for junctions formed after addition of a single complementary nucleotide (+C junction 
recovery) is expressed as a fraction of the total junctions recovered from wild type cells. Error 
bars reflect the range of means from two triplicate transfections, performed on different days. 
Mean recovery efficiencies were assessed as significantly different with confidence p<.05 (*) or 
not significantly different (ns). (c) The percentage of junctions formed after accurate synthesis 
was determined after introduction into the Polm-/-Poll-/- cell line of GCG3’ substrate together 
with 0, 1, 10, 100, or 1,000 ng of Pol µ. The means and error bars were determined as in (b).  
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Figure 3.2: Synthesis primed from ends with a paired 3’ terminus 
The recovery efficiencies for junctions formed after synthesis were determined as in Fig. 3.1b for 
cells transfected with (a) G3’-blunt or (b) GCG3’ substrates. Error bars and statistics were 
determined as in Fig. 3.1b. (c) The percentage of junctions associated with accurate synthesis 
was determined after introduction of the GCG3’ substrate together with 0, 0.1, 1, 10, or 100 ng 
of Pol λ into Polm-/-Poll-/- cells, and mean frequencies and error bars derived as in Figure 1. (d) 
Cartoon describing the primer contexts preferred by Pol µ and Pol λ for synthesis activity 
associated with cellular NHEJ.  
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Figure 3.3: Synthesis at ends that align to generate 2 nucleotide gaps  
The recovery efficiencies for junctions formed after synthesis were determined as in Fig. 3.1b for 
cells transfected with (a) GT3’, (b) GACG3’, or (c) 5’GCAA substrates. Mean recoveries of the 
most abundant product were assessed as significantly different with confidence p<.05 (*) or not 
significantly different (ns). 
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Figure 3.4: Evaluation of structural elements that distinguish polymerase activities   
Polm-/-Poll-/- cells were complemented by introducing the indicated human wild type (WT) or 
mutant polymerases together with (a) G3’ and GCG3’, (b) GACG3’, or (c) GCG3’ and GCAG3’ 
substrates. Either 10 ng (Pol µ constructs) or 1 ng (Pol λ constructs) was used for 
complementation. The percentage of the indicated synthesis-associated products was determined 
by sequencing, with error bars derived as in Fig. 3.1. 
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Figure 3.5: Effect of polymerase deficiency on efficiency and fidelity of NHEJ 
Shown are efficiencies of junction recovery determined as in previous figures, but now for all 
junction types. (a) Junctions formed with the G3’ substrate are categorized according to whether 
(i) their formation is consistent with activity of polymerase and ligase alone (dark blue sectors), 
(ii) overhangs were remodeled by nuclease activity (light blue), or (iii) overhang sequences were 
removed. Greyed positions in the cartoons at left are nucleotides we can infer are removed prior 
to joining. Products where overhang sequence is missing (iii) were grouped according to whether 
the original overhangs were precisely removed (tan), deletions extend to sites of >1 nt flanking 
sequence identity (“microhomologies”; red), or other dsDNA deletions (orange). (b, c) Sector 
areas are determined by recovery efficiencies for corresponding junction types, relative to 
matched wild type control cells, with the angle of rotation for each sector fixed for all pies within 
an isogenic cell line series. Overall joining efficiencies are listed (Jeff), and assessed as 
significantly different from the matched wild type control with confidence p<.05 (*) or not 
significantly different (ns). The resulting junction spectra were generated after introduction of 
G3’ substrate into (b) wild type and matched polymerase deficient cells, or (c) cells with and 
without Ku. Junction spectra generated after introduction of the substrate GACG3’ (see also Fig. 
3.11) into (e) wild type and matched polymerase deficient cells, or (f) cells with and without 
Ku70.  
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Figure 3.6: Effect of polymerase deficiency on resistance to ionizing radiation 
(a, b) Resistance to ionizing radiation was determined by evaluating colony-forming proficiency 
after exposure to X-irradiation, relative to untreated controls. Error bars represent the standard 
deviation from the mean of triplicate experiments. (b) Resistance to 4 Gray of ionizing radiation 
for wild type and Polm-/-Poll-/-lines, or stable subclones of the latter line engineered to express 
mouse cDNAs that were either wild type, Pol µ cat (D330E+D332E), or Pol λ cat 
(D425E+D427E). 
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Figure 3.7: Mechanism by which specialized polymerases contribute to NHEJ 
(a) Diverse end structures relevant to synthesis during NHEJ may be addressed by these 
polymerases similarly, as if alignments always generate 1 nucleotide gaps, by adjusting template 
(grayed positions) upstream (Pol µ) or down stream (Pol λ) of the nascent base pair (red) when 
gaps are longer than 1 nucleotide. (b) (i) A paired-end complex (tan) consisting of Ku, XRCC4, 
XLF, PAXX, and ligase IV (green) engages (ii) a polymerase on its cognate substrate (purple) 
before ligation, or engages (iii) a nuclease (red) that remodels the end to convert it into a cognate 
substrate for the other polymerase (cyan) before ligation. Dashed lines identify steps that only 
rarely allow for successful repair.   
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Figure 3.8: Synthesis primed from ends with an unpaired 3’ terminus 
The G3’ substrate (described in cartoon) was introduced into MEFs as described in Figure 3.1b, 
except using a panel of MEFs generated independently, derived from mice from different litters. 
Joining efficiency was determined by qPCR as with Figure 3.1b. The proportion of recovered 
junctions formed after synthesis of a single complementary base (+C junction recovery) was 
approximated here by assessing the fraction of products sensitive to restriction enzyme specific 
for this junction (NsiI). Error bars reflect the range of means from two triplicate transfections, 
performed on different days. ND; not detectable (recovery efficiency <0.01). 
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Figure 3.9: Synthesis at ends with partly complementary 5’ overhangs 
The 5’GCA’ substrate (described in cartoon) was introduced into MEFs as described in Figure 
3.1b. Joining efficiency was determined by qPCR. The proportion of recovered junctions formed 
after synthesis of a single complementary base (+T junction recovery) was approximated by 
assessing the fraction of products sensitive to restriction enzyme specific for this junction 
(HpyCH4V). Error bars reflect the range of means from two triplicate transfections, performed 
on different days. ND; not detectable (<0.01). 
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Figure 3.10: Synthesis at ends that align to generate 2 nucleotide gaps 
The GCAG3’ substrate (described in cartoon) was introduced into MEFs as described in Figure 
1b, but using a panel of MEFs generated independently, derived from mice from different litters. 
Joining efficiency was determined by qPCR, but the proportion of recovered junctions formed 
after synthesis of TC was approximated by assessing the fraction of products sensitive to 
restriction enzyme specific for this junction (AatII). Error bars reflect the range of means from 
two triplicate transfections, performed on different days. ND; not detectable (recovery efficiency 
<0.01). 
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Figure 3.11: Legend including junction sequences 
Synthesized nucleotides in pink. Overhang sequence retained in each junction sequence is listed 
in black text. Grey text refers to opposite strand sequence that was lost from the product. 
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Figure 3.12: Sensitivity of polymerase deficient cells to agents that damage DNA (a) 
Resistance to ionizing radiation as in Figure 6, except using a panel of MEFs generated 
independently, derived from mice from a different litter. (b) Cellular resistance to methyl 
methanesulfonate (MMS) was determined after a 4 hour exposure, and (c) resistance to paraquat 
after exposure for 18 hours. Error bars represent the standard deviation from the mean survival at 
each dose. 
  
 99 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.13: Validation of cellular NHEJ assay 
a) Representative substrates were HinfI digested, 32P-labeled, and resolved by denaturing 
polyacrylamide gel electrophoresis. b) A library of a control oligonucleotide with an embedded 
degenerate tetramer was prepared for sequencing from the same number of input molecules and 
using an identical workflow as experimental samples. The frequency of reads for each different 
sequence, from a total of 11776 reads, is plotted for each of the predicted 256 (42) sequences. c) 
Mean frequency of single nucleotide substitutions for joined products of GACG3’ recovered 
from wild type (triangles), and pol µ deficient cells (squares) over a portion of the junction 
flanking the ends. Sites of cellular polymerase-dependent gap filling are bolded. Error 
frequencies at each position of the experimental samples fall within one standard deviation 
(dashed lines) of the mean substitution error (solid line) derived from sample processing (as 
determined for a control amplicon generated by T4-ligation of 5’GATC in vitro), except at two 
positions in which substitution rate is higher and largely attributable to repeated C addition by 
pol µ (see also Fig. 3.3a). 
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Substrate Primers Restriction Enzymes 
G3’ 5’-CAAGTGGACCACATGTCTTAGCTGTATAGTCAGGGAAATC-3' AhdI 5’-CCGCCGACGCCATGTCACACCCATCTCAGACTGGCTACCC-3’ 
G3’-Blunt 5’-TCAGTATCCTGTGACTGCACACCCATCTCA-3' BciVI/PvuII 5’-GTGGTCAGCTGGCTTAGCTGTATAGTCAG-3’ 
GCG3’ 5’-TTTTTGCCACGCTGGCTTAGCTGTATAGTCAGGGA-3' BglI 5’-CACCTGCCTCGCTGGCACACCCATCTCAGACTGGC-3’ 
TG3’ 5’-TTTTTGCAATGCAATCGCTTAGCTGTATAG-3' BsrDI 5’-TCACGCAATGCAATCACACCCATCTCA-3’ 
GACG3’ 5’-CAAGTGGTCCACCGTCATGGCTTAGCTGTATAG-3' BstXI 5’-GCCGACCAGCGTCATGGCACACCCATCTCA-3’ 
5’GCAA 5’-CAAGTGGTCTCCGCAAATCGCTTAGCTGTATAG-3' BsaI 5’-GCCGAGGTCTCAGCAAATCACACCCATCTCA-3’ 
5’GCA 5’-TCATGCTCTTCCGCAATCACAGAAAATCGCTTAGCTG-3' BspQI 5’-CAAGGCTCTTCAGCAATCTGGACGAATCACACCCATCT-3’ 
 
Table 3.1: Primers and restriction enzymes used to generate substrates 
Listed are the primers and restriction enzymes used to generate substrates in this study. 
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CHAPTER 4: DISCUSSION 
 
Mammals rely on nonhomologous end joining for the efficient repair of chromosome 
breaks. These breaks possess a variety of end structures, some lacking sequence complementarity 
or containing nucleotide damage, which are not always amenable to ligation. My work shows 
that when competing alignment-driven resolutions are available, some requiring end processing, 
NHEJ first attempts to directly ligate the pair of ends. If direct ligation fails, NHEJ will deploy 
several different processing factors, such as nucleases and polymerases, in order to modify 
incompatible DNA termini and render them ligatable. Two of the end remodelers critical for 
repair of incompatible ends are Pol λ and Pol µ, members of the X family of DNA polymerases. 
These polymerases are preferentially active on distinct substrates but can partially compensate 
for one another via less accurate paths. Thus, I propose that NHEJ systematically employs these 
various resolution strategies in order to efficiently resolve DSBs with diverse end structures. 
4.1 Tolerance at the ligation step 
Ligation is critical for NHEJ. The ligation complex encounters a variety of end structures 
at DSBs, some not capable of perfect/straightforward alignment. As a result, having a ligase 
capable of joining even a subset of these end structures directly (i.e. without requiring prior end 
processing) would significantly increase the flexibility of NHEJ as well as limit sequence loss 
due to end remodeling. 
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 In vitro studies indicated that NHEJ’s ligase complex is capable of directly ligating a 
variety of difficult-to-align termini 1, 2, 3, 4, 5, 6, 7. Using the assay described in Chapter 2, I was 
able to systematically vary end structures of substrates to determine the extent to which the LIG4 
complex can bypass terminal mispairs and mild damage in cells. I show that the LIG4 complex is 
capable of directly ligating DNA ends that contain mild helical distortions. Specifically, it can 
directly ligate mispairs as well as a terminal 8-oxoguanine (GO):C pair at the ligation site. This 
finding is in agreement with previous in vitro studies 1, 2, 3, 6. Thus, it would be apt to describe 
LIG4 as a translesion ligase.  
There are, however, variations in the degree to which LIG4 can directly ligate these 
substrates. Mispairs whose conformations are a similar width to matched pairs (e.g. 
purine:pyrimidine mispair) were better tolerated. In addition, mispairs located 5’of the strand 
break (overhang) were tolerated better than those located 3’ of the break, a pattern consistent 
with observations of other eukaryotic ligases in vitro 8, 9, 10. This pattern can be explained if LIG4 
interacts with DNA in the same manner as the other mammalian ligases 11, 12, where the ligase 
encircles the DNA and the 5’ phosphate is positioned in the active site. The extensive contacts 
between the 5’ phosphate and the active site help to correctly position it. Since the 3’ end does 
not make as many contacts, it must rely on intrinsic base pairing to correctly position itself for 
the reaction 11. Thus, distortions due to mispairing at the 3’ end would prevent the 3’OH from 
aligning properly during ligation.    
Interestingly, I found that the substrate with a terminal GO was the most dependent on 
LIG4-mediated joining of all those tested. I found that not only is NHEJ particularly efficient at 
ligating ends possessing a terminal GO, but also directly ligates these termini without prior 
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removal of the GO. The ability of the LIG4 complex to directly ligate this GO:C base pair also 
indicates that LIG4 is a translesion ligase.  
It is not clear what element(s) present in the NHEJ machinery, and not in the alternative 
end joining machinery, facilitates the direct ligation of terminal GO. The simplest explanation 
would be that there is an element in LIG4 that is missing in the alternative end joining ligases. 
Two possible candidates are K345 and an insert between alpha5 and alpha6 of the DBD of LIG4, 
residues 111-121. Recent structural studies indicate that K345 may confer increased flexibility in 
locating the 3’OH, and the DBD insert may be involved in additional DNA binding 13. Together, 
these elements may facilitate ligating a mild helix-distorting end structure such as GO:C pair (as 
well as previously mentioned mispairs). 
LIG4 does not act alone, however. XLF has been shown to stimulate joining of mispaired 
DNA ends in vitro 2, 14. This stimulation may be the result of an association between XLF and 
XRCC4. Together with DNA and LIG4, they form a protein splint that may stabilize the DNA 
ends 15, 16, 17, 18, 19, 20, 21. Joining efficiency is similarly reduced in XLF-deficient HCT116 and an 
isogenic LIG4-deficient cell line for all substrates in this study, both with incompatible and 
compatible end structures (data not shown). Thus, it is unclear whether the ability to directly join 
the substrates with terminal mispairs in this study is dependent on this protein splint or XLF in 
general. One could disrupt filament formation by mutating residue L115 in XLF or the 
hydrophobic pocket in the head domain of XRCC4 (residues M59, M61, F106, and L108) and 
test end joining of the substrates in vitro as well as in cells harboring these mutations 15, 17, 22. The 
existence of this protein splint suggests another possible proposal for the element responsible for 
NHEJ’s ability to directly ligate terminal GO:C. The protein splint may act to stabilize the DNA 
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termini sufficiently to allow/facilitate the adoption of the anti conformation by GO, which would 
allow for its pairing with cytosine. 
4.2 End processing is adaptive 
 The ability of LIG4 to directly ligate the substrates in this study varied from roughly 85% 
to 6%, depending on the substrate. I found that polymerases and nucleases were engaged as the 
distortion caused by the terminal mispair increased and, thus, the ability to directly ligate 
decreased. Substrates with 3’ overhangs experienced more end processing than their 5’ overhang 
counterparts because mispairs located on the 3’ end of the break are less tolerated (see preceding 
section). 
Regardless of the mispair polarity, though, a two-step resolution strategy almost 
completely compensated for the loss in direct joining. The first step is alignment-based gap 
filling of the initial overhangs, which is followed by the ligation of the remodeled ends. The 
contribution of nuclease-dependent resolutions, which presumably require more enzymatic steps, 
did not change significantly among different mispairs of the same overhang polarity. Thus, end 
processing is not simply stochastically engaged. Instead, NHEJ efficiently adapts in response to 
the initial end structure and possibly in response to subsequent remodeling of the initial structure 
as I suggest in Chapter 3. I propose that NHEJ prioritizes resolution strategies based on the 
number of enzymatic steps involved, with the strategy requiring the fewest steps (direct ligation) 
being employed first followed by more complex resolutions. This means that there is a hierarchy 
of DNA transactions in which ligation, synthesis, and excision proceed in that order.  
The efficient transition from direct ligation to synthesis in response to mispair identity as 
well as the overall lack of heterogeneity in joining products suggests that transitions between 
these DNA transactions occur within a sustained paired-end complex comprised of the DNA 
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ends in complex with the core NHEJ factors. Integration into a stable paired-end complex may 
reduce heterogeneity by inhibiting the activities of alternative end joining (Alt-EJ) pathways 
(reviewed in 23). The newly discovered end joining factor, paralog of XRCC4 and XLF (PAXX), 
has been suggested to stabilize the NHEJ core complex at DSBs 24. It is possible, then, that 
changes in PAXX (e.g. expression) could play a role in switching from classical NHEJ to Alt-EJ. 
However, DSBs where LIG4 cannot directly ligate the ends pose a unique challenge to 
polymerases. In these cases, an intact template strand cannot be used to replace the lost or 
damaged nucleotide. Nevertheless, I show that two members of the mammalian X family of 
DNA polymerases – Pol µ and Pol λ  – are able at meet this challenge in cells. In Chapter 3 I 
systematically varied both substrate and polymerase to identify the contexts in which each 
polymerase is specifically active during cellular NHEJ. I found not only that Pol λ and Pol µ are 
preferentially active on distinct substrates, i.e. cognate substrates, but that the presence of at least 
one polymerase was required for efficient NHEJ.  
4.3 Polymerase specialization increases flexibility and accuracy of NHEJ 
4.3.1 Pol λ  
In agreement with previous in vitro work, I found that Pol λ requires a paired primer 
terminus from which to prime synthesis 25, 26. In fact, Pol λ is responsible for most of the 
synthesis activity on substrates with paired primer termini used in this study regardless of gap 
size. The data indicate that, although Pol λ and Pol µ can both synthesize across a 1 nt gap, Pol λ 
is uniquely able to processively fill a 2 nt gap. Using substrates with both 1 and 2 nt gaps, we 
found that Pol λ employs a “1 nucleotide gap rule” when synthesizing across gaps by using its 
scrunch pocket as had been shown previously in vitro 27. This scrunch pocket provides a means 
 109 
of promoting accuracy during fill-in of longer gaps, on which Pol µ is less efficient as well as 
less accurate (discussed below and in 28).  
4.3.2 Pol µ 
In Chapter 3 I found that Pol µ retains significant activity on all of the substrates included 
in this study. This flexibility is partly because Pol µ, and not Pol λ, can prime synthesis from 
unpaired as well as paired primer termini as has been shown in vitro 25, 28. There are a few 
structural elements specific to Pol µ that may underlie this unique ability. The first is an extended 
loop in Pol µ’s palm subdomain (Loop1).  This loop is longer in Pol µ than Pol λ and has been 
suggested to act as a template strand surrogate 25, 29. We found that deletion of the loop (C369-
F385) or substitution of a residue contributing to the loop’s rigidity (F385A) impairs Pol µ’s 
activity in this context in cells. Neither of these elements is necessary for Pol µ to synthesize 
from a paired primer terminus, however. Thus, Loop1 increases the range of substrates on which 
Pol µ can act.  
His329 may contribute to Pol µ’s ability to extend from an unpaired primer terminus in 
cells as it contributes to the proper positioning of the primer terminus and incoming dNTP. An 
alanine substitution at this residue reduces Pol µ’s activity on a substrate with an unpaired primer 
terminus while having little impact on a substrate with a paired primer terminus in vitro 30. I 
would expect similar results with this mutant in our cellular assay. Given that these elements 
increase Pol µ’s flexibility, it might be interesting to introduce them into Pol λ and test whether it 
gains the ability to prime synthesis from an unpaired primer terminus in cells. 
Another unique feature of Pol µ is the way it identifies template. I found that on gaps of 2 
nt, Pol µ fills in only one nucleotide of the gap by skipping ahead. Pol µ skips the first template 
base and identifies the unpaired base adjacent to the downstream 5’ phosphate as the templating 
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base. The structural elements have been elucidated in a recent study (Moon et al, in preparation), 
which support our finding of Pol µ skipping ahead in cells. Using this “1 nucleotide gap rule” 
increases Pol µ’s flexibility, allowing it to remain active in the context of a 2 nt gap. However, it 
clearly promotes error, as only a single nucleotide will be incorporated. Pol µ’s activity on this 
substrate would be best restricted to instances when Pol λ, which is preferentially active in this 
context, is unable to engage. 
4.3.3 Polymerases are required for nuclease-dependent resolutions 
A considerable amount of joining occurs after nuclease remodeling of end structures. The 
data indicate that the polymerases maintain their preferential activity even after nuclease 
remodeling of the initial end structure, as certain products of nuclease activity are dependent on 
one polymerase or the other. This finding can best be explained if the cognate substrate of one 
polymerase can effectively be converted into the cognate substrate of the other via nuclease 
activity. This mechanism would also support the model proposed in Chapter 2, in which 
transitions between the polymerase and nuclease occur within a sustained paired-end complex. 
Here, the ligase and end remodelers can rapidly sample different end alignments and act on them 
iteratively, thereby increasing the likelihood of ligation with minimal changes made to the end 
structure (e.g. sequence loss). It is this ability to transition between cognate substrates that 
explains why loss of a single polymerase has a relatively mild impact. The combined activity of 
the nuclease and remaining polymerase, thus, compensate for the loss of the other polymerase. 
In the absence of polymerase activity, nucleases should be able to sufficiently remodel 
ends to promote ligation. Surprisingly, we found that NHEJ in cells deficient in both 
polymerases is profoundly defective for certain substrates, where NHEJ efficiency and product 
spectra were similar to cells deficient in Ku. Additionally, these cells are significantly more 
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radiosensitive than cells deficient in either polymerase alone. These results indicate that the 
polymerases, in addition to synthesizing across gaps, may also have a role in recruiting end-
remodeling nucleases. 
4.4 Directions for Future Research 
A key direction for future research is to determine exactly which nuclease is responsible 
for remodeling the ends of DSBs when gap filling by Pol λ or Pol µ cannot proceed. One 
plausible candidate is Artemis whose endonuclease activity trims ssDNA ends and cleaves 
hairpin intermediates during V(D)J recombination 31, 32. Cells deficient in Artemis, specifically 
Artemis’s endonuclease activity, are radiosensitive 33. It has been suggested that this 
radiosensitivity is because Artemis is required to trim ligation-blocking ends such as 3’ 
phosphoglycolate ester (PG) 33, 34. This radiosensitivity finding could also support the model 
described in Chapter 3 if it were also responsible for remodeling DSB termini to generate 
cognate substrates for either polymerase. Using the same cellular NHEJ assay discussed in 
Chapter 3, one could expect that, for a non-cognate substrate, joining efficiency and product 
spectra would be similar in cells deficient in both a single polymerase and Artemis to cells 
deficient in both polymerases if Artemis were responsible for the substrate remodeling. 
Another direction for future research is to examine how the different end remodelers, 
such as Artemis, gain access to the DSB ends as well as how they are recruited. For the transition 
from ligation to synthesis, the proposal I currently favor is that it is mediated by LIG4’s adoption 
of an unproductive open conformation on the DNA after a failure to ligate. This open 
conformation exposes the ends to processing enzymes such as polymerases and nucleases and 
possibly serves to recruit some end processing enzymes. For example Pol λ, Pol µ, and Artemis 
have direct interactions with LIG4 35, 36, 37. An open conformation may expose the surfaces 
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mediating these interactions or simply increase the affinity of these factors for the complex. 
Other end processing factors (e.g. polynucleotide kinase/phosphatase (PNKP) 38, and aprataxin & 
PNKP-like factor (APLF) 39, 40) associate with XRCC4, a component of the LIG4/XRCC4 
complex. An open LIG4 conformation may similarly impact these enzymes. Such a mechanism 
would indicate that LIG4 plays a crucial role in mediating NHEJ regardless of whether or not it 
is successfully able to ligate ends, which is in agreement with recent studies indicating a non-
catalytic role for LIG4 in NHEJ 41, 42. 
Post-translational modifications may provide an additional layer of regulation of end 
processing. Previous studies indicate that end processing may be governed by DNA-PKCS, with 
access to the ends being mediated by phosphorylation of DNA-PKCS. Phosphorylation of DNA-
PKCS’s ABCDE cluster appears to facilitate end access, while phosphorylation of the PQR 
cluster appears to block end access (as reviewed in 43). Thus, DNA-PKCS phosphorylation seems 
to mediate whether or not access is granted to the ends. A direction for future research would be 
to determine exactly which events trigger phosphorylation of these sites as well as the exact 
location of the sites within DNA-PKCS. 
In addition to being that target of phosphorylation, DNA-PKcs is also responsible for 
phosphorylating other factors involved in NHEJ. Importantly, XRCC4 44, XLF 45, and LIG4 46 
are targets for phosphorylation by DNA-PKCS. These phosphorylation events reduce DNA 
binding and disrupt the ligase complex, including the LIG4/XRCC4/XLF protein filament 47. 
This “loosening” of the filament might be the cause of LIG4’s adopting the open confirmation 
described above. This may be one of the ways that DNA-PKCS acts to facilitate end processing. It 
would be interesting to see if this phosphorylation could be induced by a failed ligation attempt.  
 DNA-PKCS also promotes the function of several end-processing factors. One factor in 
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particular, Artemis, is of particular interest as it possess nuclease activity that can be directly 
linked to NHEJ via its role in V(D)J recombination 31. Artemis has been found to interact with 
both DNA-PKCS as well as LIG4. Its interaction with phosphorylated DNA-PKCS appears to be 
necessary for Artemis’s endonuclease activity 48. DNA-PKCS mediated phosphorylation of 
Artemis may also play a regulatory role in Artemis’s activity at DSBs 32. Thus, DNA-PKCS may 
be a key player in granting access to, and promoting processing of, DNA ends when ligation 
cannot proceed. 
Given the disparate activities of Pol λ and Pol µ, the selection of which polymerase to 
employ is an important determinant of NHEJ’s efficiency and accuracy. One strategy for 
polymerase selection is a hierarchical engagement of the polymerases, with Pol λ engaging ends 
first. While Pol µ is the more flexible polymerase, it is also more prone to error relative to Pol λ. 
In addition to generating error by “skipping ahead” on 2 nt gaps, Pol µ may also generate 
dinucleotide expansions and incorporate ribonucleotides into repair junctions which has been 
shown in vitro 49, 50, 51, 52. This hierarchical strategy would, thus, minimize potential error during 
repair. What might mediate such a strategy? 
Both Pol µ and Pol λ interact via their BRCT domains with Ku and XRCC4-LIG4 25, 26, 53, 
54, 55. Despite binding to the same sites, differences within their BRCT domains suggest that 
interactions with the NHEJ core complex may differ between them 56, 57. These different 
interactions may increase one polymerase’s affinity for the core complex relative to the other, 
supporting a hierarchical employment strategy. One could generate polymerase chimeras in 
which Pol λ’s BRCT is replaced with Pol µ’s and vice versa. Then, compare the relative binding 
affinities for the wild type and chimeric proteins for the core complex. Pol λ would require a 
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significantly higher binding affinity for the core complex if it were engaged first as I have 
suggested. 
Coupled with affinity for the core complex, expression levels may also determine which 
polymerase is recruited in a given instance. Complementation studies performed in Chapter 3 
indicate that Pol µ exists at subsaturating levels, at least in MEFs, while Pol λ does not. This 
finding suggests that Pol µ’s affinity for the core complex is less than that of Pol λ. In addition, 
Pol µ levels increase in cells during V(D)J recombination, when Pol µ-mediated variability is a 
benefit 58.  Thus, perhaps Pol µ expression is kept low to support Pol λ-specific engagement 
during NHEJ. 
4.5 Concluding Remarks 
 Nonhomologous end joining (NHEJ) is the predominant repair pathway of DSBs in non-
cycling mammalian cells. In this dissertation I have shown how cellular NHEJ adapts to resolve 
DSBs that possess end structures that lack sequence complementarity or containing nucleotide 
damage. These adaptations include the ability of LIG4 to act as a “translesion ligase” as well as 
its ability to act as a gatekeeper of the DSB ends. I proposed that LIG4’s transition from a closed 
to an open confirmation ability permits specific end remodelers access to the ends. My data 
indicate that two of the key remodelers in cellular NHEJ are the X family polymerases Pol λ and 
Pol µ. These polymerases are preferentially active on distinct substrates and have distinct 
mechanisms for gap filling. Thus, they have largely non-overlapping roles in cells. Further, I 
have proposed that to minimize pol µ-mediated error, NHEJ preferentially employs the more 
accurate Pol λ first. My work has, therefore, demonstrated that NHEJ is able to systematically 
adapt to different end structures, which speaks to the incredible flexibility of this pathway.  
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